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INTRODUCTION 
 
 Siddha system of medicine, which has been prevalent in the ancient tamill and, is 
the foremost of all other medical system in the world.  The unique nature of this system is 
its continuous services to humanity for more than 10,000 years, in combating diseases 
and in maintaining the physical, mental and moral health.  Siddhar’s are spiritual scientist 
explored the nature and evolved Siddha science from the findings of the experiments. 
They educated this disciple and propagated Siddha concepts. 
  The Siddha system grew though the work of Agathiyar, Bogar, Thirumoolar and 
others. 
 Siddhar’s knowledge of iatrochemistry, minerals, metals and plants was 
stupendous. This was successfully used system from the immemorial. 
 In Siddha system, chemistry had been found developed into a science auxiliary to 
medicine and alchemy, it was found useful in the preparation of medicines for curing all 
sorts of suffering, spirituals as well as corporeal and also transmutation of baser metals 
into gold. The knowledge of plants and minerals was of very high order.1 
 Siddha medicine incorporates wide usage of heavy metals and minerals for curing 
chronic illness. 2 
 The scientific evaluation is needed to validate its preciousness. The Siddha system 
has not only the curative and preventive effects on different diseases but also paves the 
way for longevity and immortality. WHO has also recognized Indian system of medicine 
has an effective alternative medicine in the place of conventional allopathic system of 
medicine. 
 In spite of strong efficacy in iddha system is facing crisis in getting appreciation 
among the mass. The western scientific community condemned the Indian system of 
medicine to market the drugs reporting the presence of heavy metals like arsenic, lead, 
cadmium & mercury. 
 In Siddha system all drugs must be purified individually as told in the text before 
converting into medication. 
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   ‘Xd;whd ruf;Fr; Rj;jp 
ahtUKiwf;ftpy;iy 
fz;zhd ruf;Ff; nfhy;yhq; 
ifa;koe; jPu tpl;lhy; 
gz;zhd kUe;J Nrh;e;Jg; 
gUfpbygpzpgh upf;Fk; 
ez;zhd nre;J} uq;f 
spilgLk; ed;whNj’3 
         (Agasthiyar Kanma Soothiram) 
 
Detoxification and purification process of raw days have been meticulously 
described in siddha literature where, purification is primary step in removing impurities 
of the drug.4 
 
Standardization is the process of implementing and developing technical 
standards. Standardization helps to maximize, compatibility, interoperability, safety, 
repeatability or quality. It can facilitate commoditization of formerly custom process.5 
Aim of Standardization is to scientifically valid the quality and safety of single drugs of 
herbals, minerals, metals animal origin and also compound formulations as per API 
guidelines. 
 
 In Siddha system, Metallic preparations are use to cure many challenging disease 
before preparation of medicine each drug must be purified to remove the impurities. 
 The purification of metallic drug used in Siddha constitutes a step considered as 
crucial to ensure the quality and safety of medicines  
 
 No medical preparation is done without prior Suddhi process 6 
 
 This process helps metallic drug to lose their undesirable or toxic effect and there 
by aid better dosage efficacy 
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 Manosilai is one of the metallic drug, cures lot of disease, particularly of effective 
chronic disease, like, leprosy, fever with chill, asthma, eye disease, urinary tract infection 
and kabha disease.7 
 
 Manosilai is also included as the ingredients in the preparations like Sivanar 
Amirtham, Kasthoori karuppu, Vishnu chakkaram, Bramananda bairavam and Gandaga 
Sudar thailam. 
 
 Being toxicology student I want to study of the chemical changes occur during the 
purification process of Manosilai. 
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AIM: 
To standardize the purification process of Manosilai. 
 
OBJECTIVES: 
¾ To discover the importance of purification process. 
¾ To analyse the changes during purification process by chemical analysis. 
¾ To analyse the changes during purification process by physico – chemical 
analysis. 
¾ To evaluate the importance of purification by comparing the unpurified and 
purified drug by Quantitative analysis. 
¾ XRD 
¾ SEM 
¾ ICPOES 
¾ FTIR 
 
¾ To access before and after purification of Pesticide resides 
¾ To access before and after purification of Microbial Load 
¾ To access before and after purification of Aflotoxin  Count 
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kNdhrpiy :  
 ,J tpisT gh~hzk; 32-y; xd;W. ,J mupjhuk; mfg;gLk; G+kpf;Ff; fPNo 
Njhz;l fpilf;Fk;.8 
NtW ngah;fs; :  
¾ rpiy> 
¾ tpy;>  
¾ ehd;Kfd; Njtp>  \ 
¾ ruNrhjp> 
¾ thzp> 
¾ nts;sr;rp> 
¾ jhkiuthrpdp. 
,J gpwtpr;ruf;F> itg;Gf;F ruf;F vd ,U tifg;gLk;. 
 Ie;J gq;F nts;isghlhzk;> %d;Wgq;F fe;jfk; Nru;j;J      
itg;Gr;ruf;F nra;ag;gLfpwJ. 
tiffs;: 
¾ rpte;j mupjhuk; 
¾ klyupjhuk; 
¾ Fjpiug;gy;ghlhzk; vd;Wk;> 
 
NkYk; Nfh~hap mDNghf itj;jpak; gpuk;k ufrpak; ghfk; 2y;  
¾ ]ahq;fpak; - ypq;fk; Nghy;rpfg;ghAk; nfhQ;rk; gr;ir epwkhAk;   
  gpufhrkw;W ,Uf;Fk; 
¾ futPuk; - rpfg;ghAk;> #uzkhAk;> gSthAk;; ,Uf;Fk;. 
¾ jpypfz;lk;- nfhQ;rk; rpfg;ghAk;> gr;irepwkhAk; ,Uf;Fk; vd;Wk;  
     tifgLj;jg;gl;Ls;sJ. 
NkYk; rhk;grptk;gps;is jkpo; mfuhjpapy; 
¾ kNdhrpiy 
¾ rpahkhq;fp 
¾ futPuk; 
¾ Jtpfz;lk; vd;Wk; $wg;gl;Ls;sJ. 
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kNdhrpiy nghJf;Fzk;. 
“nfhba F~;lk; fha;r;r eLf;fyI fy;ypapiug; 
Gr;rpye;jpg; NgrWk Ndhrpiyf;Fg; NgR.” 
 
nghUs; : 
kNdhrpiyapdhy;> rUkFl;lk; espu;Ruk;> mIfy;ypfhNuhfk; (Ml;Lf;fOj;jpy; 
cz;lhFk; mjpiug; Nghd;W nfhg;Gsq;fs;. ,J Foe;ijfSf;F fhZk; Neha;)> 
,iug;G (Rthrk;)> rpye;jptplk; Kjypad jPUk;. kw;Wk; fhrk;> fgNeha;> fz;Nzha;> 
*j;jpuf;fPupr;ruk; Kjypad jPUk;. 
 
nghJ Fzk;: 
 “Fl;lq;nfhbauzq;$We;jpkpu;gilAk; 
tl;lkpLq;fpue;jp td;iknayhk; -tpl;Lg;Nghk; 
 fha;;r;ry; eLf;fyI fd;dpapiug; Gr;rpye;jp 
 Ngr;rWk Ndhrpiyiag; Ngz;.” 
Fzk; 
 kNdhrpiyahy; Fl;lk;> mOfYw;w tpuzq;fs;> jpkpUld; cs;s gilfs;> 
fpue;jpGz;fs;> Ruk; Fsph; mIfy;ypfhNuhfk; (Foe;ijfSf;F fhZk; 
fd;dpg;g+itg; Nghd;w ePz;l nfhg;Gsq;fs;)> Rthrfhrk;> rpye;jp tplk; 
Kjypaitfs; jPUk;. 
 
cgNahfpf;Fk; Kiw : 
,jid jdpahf cs;Sf;F nfhLg;gJ fpilahJ. ,jid gpw ruf;FfSld; 
$l;b fUg;G> khj;jpiufshf gad;gLf;Jfpd;wdh;. 
nra;if: 
¾ cly;Njw;wp> 
¾ ntg;gfw;wp> 
¾ cly;cukhf;fp 
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tof;fj;jpy; cs;s rpy Kiwfs; 
¾ gTj;jpug; Gz;fSf;F kw;iwa nghUs;fSld; fye;J    
ntspg;gpuNahfkhf gad;gLj;jyhk;. 
¾ kNdhrpiyia ehAUtpr;rhk;gYld; fye;J ntz;Fl;lj;jpw;F Nky; g+r;rhf 
gad;gLj;jyhk;. 
¾ kNdhrpiy> jhsfk;> Nrq;nfhl;il xU tuhfd; vLj;J J}shf;fp 3 gyk; 
ey;nyz;nzapy; tpl;L nts;shl;L ePh; xU gbtpl;L fha;r;rp 3 Ntis 
fhjpy; tpl fhjpy; rPo; tbjy; FiwAk;.9 
¾  Rj;jp nra;j kNdhrpiy 1 ghfk; rq;F gw;gk; 2 ghfk;>  kpsF ½  ghfk;> 
,e;Jg;G ¼ #uzpj;J Njd; fye;J fz;zpy; fypf;fkpl Rf;fpyNuhfk;> 
jpkpu;Nuhfk; fz; Cis FzkhFk;. 
¾ Nkw;gb #uzk; nra;j kNdhrpiy - #uzk; nra;J>   ePhpy; miuj;J 
fz;zpy; fypf;fkpl Id;dp ghj Ruk; eptu;jjpahFk;. 
¾ rpWNjf;F> Rf;F ,itfis fye;J cs;s ,iug;G jPUk; eQ;Rf;FwpFzk;.  
 
Rj;jp Kiwfs; 
 
 ,Q;rpr;rhW> gor;rhW> gRtpd;Nkhh; ,itfspy; xd;iw kNdhrpiyf;F tpl;L> 
xUrhkk; ed;wha; miuj;J> cyh;j;jp vLf;fr; nra;ATk; 
 kNdhrpiy xU gyk;> ,jidr; rpW Jz;Lfshfr; nra;J 5gyk; Gspj;j 
Nkhiug;gPq;fhd; ghj;jpuj;jpy; tpl;L> mjpy; ,j;Jz;Lfis ,l;L nta;apypy; 
itj;Jf; fpswpf; nfhLf;f Ntz;Lk;.  khiyapy; vLj;J ePhpypl;Lf; fOtp> 
Kd;dsT Gspj;j Nkhh; tpl;L> kWehs; nta;apypy; itj;J Kd; Nghy 
nra;aTk;.  ,t;tpjk; %d;WKiw nra;ar; Rj;jpahFk;. 
 Ie;J gyk; nfhbNtyp Nth;g;gl;ilia ¾ gb ePh;tpl;L> %d;wpy; xd;wha; 
fha;r;r> mjpy; 1 gyk; kNdhrpiyaj; Jz;Lfisf; FbePhpy; gLk; gb 
Ml;Lf; nfhOg;ig ,l;L mjpy; kNdhrpiyj;Jz;Lfisj; Jzpapy; 
Kbe;JNghl;L> Jzp fUFk; tiu tWj;njLj;J vz;nza;g; gir ePq;f 
Jzpahy; Jilj;Jf; nfhs;sNtz;Lk;.  ,r; rf;jp itj;jpa ,ur thj 
KiwfSf;F gad;gLk;. 
 kNdhrpiy 2 ghyj;ij fpop fl;bg; ngz; nts;shl;L %j;jpuk;  1/4  gbapy;  
Njhyhae;jpukhf ePh; Rz;L tiu vhpj;Jf; fOtp vLj;J> fy;tj;jpypl;L 
nts;shl;L gpj;J ePh; tpl;L miuj;J> rpW tpy;iyfshfr; nra;J> 
nta;apypYyh;j;jpf; fy;tj;jpypl;L Kd;NghyNt gpj;J ePh; tpl;L miuj;J 
cyh;j;jpf; nfhs;sTk;. ,t;tpjk; VOKiw nra;ar; Rj;jpahk;.7 
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 kNdhrpiyia fpofl;b fhbapy; Nghl;L vhpj;njLj;J kPz;Lk;           
Ml;L %j;jpuj;jpy;Jyhae;jpukhf fl;b vhpj;J vLf;f Rj;jpahFk;. 
 kNdhrpiyia nky;ypa Jzpapy; %l;ilfl;b Ml;L %j;jpuj;jpy; 
Jyhae;jpukhfvhpf;f Rj;jpahFk;. 
 mfj;jp,  ,Q;rp, fhpryhq;fz;zp ,itfsp;y; Ntfitj;J vL;f;f Rj;jpahFk;.10 
 kNdhrpiyia Rj;jkhd fy;tj;jpypl;L gRNkhuhy; xU [hkk; miuj;J 
vLf;f Rj;jpahFk;. 
 kNdhrPiyia ,Q;rpr; rhw;wpy; xU [hkkiuj;J khj;jpiufshfr; nra;J 
cyh;j;jpf; nfhs;f  
 
gh~hzq;fs; Rj;jp kNdhrpiyf;Fk; nghUe;Jk; 
“nrhy;ypTpl;l gh~hz tu;f;fe; jd;idr; 
RUf;fhfj; njhshe;jpukha; tpl;lk; Nghl;L 
ney;Yjdpy; %o;f itj;J mtpj;Jf; nfhs;S 
epiyj;j Rj;jp ahFkpJ eprkha;j; jhNd 
nty;ynt gztpiljd; nfhz;lhy; ey;y 
tpUg;gkha;r; rfy Nehnay;yhk; NghFk; 
Gy;ywptha;g; gz;bjw;Fg; gj;jp nrhd;Ndd; 
Gfywpa ahNfhG Gyd; nrhd;dhNu.”13 
 
gh~hzfspd; nghJ Rj;jp   
  Fg;igNkdp urk; 
  fw;whiog;ghy; 
  gourk; 
  nrk;gUj;jp ,iyr; rhW 
  ntw;wpiyr; rhW 
tiff;F 1 gb 
  Kiyg;ghy; ¼ gb 
  Mjpy; ghiwcg;G 
  ntbfhuk; 
       gbfhuk;   
etr;rhuk;  
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tiff;F ¼ gyk; J}s; nra;J fye;J fpspf;fl;bapl;L epoyhf 
fhw;wpy;yhtplj;jpy; 15 ehs; itj;njLj;J fhbapy; Cwitj;J vLf;f Rj;jpahFk;.12 
 
kNdhrpiy nfhz;L nra;ag;gLk; gpw kUe;Jfs; 
¾ rh;tNuhfFspif 
¾ MWKfFspif 
¾ uhkghzkhj;jpiu9 
¾ urfe;jp nkOF 
¾ f];J}hp khj;j;iu 
¾ tp~;Zf;rf;fuk; 
¾ fe;jfRlh;ijyk; 14 
¾ gh~hz khj;jpiu 
¾ gpukhde;jigutk; 
¾ kNdhrpiy gw;gk; 
¾ rj;jp khj;jpiu 
¾ ghrkhj;jpiu 
¾ jphptq;fnre;Juk; 
¾ kfhghlhznre;Juk; 
¾ urtPuehf nre;Juk;15 
¾ uj;jpdhjp Fspif 
¾  etur nkOF16 
¾ Mde;j igut khj;jpiu 
¾ jhgRu khj;jpiu 
¾ kfhNfhlh#op khj;jpiu 
¾ jrhtjhu Ngjp 
¾ gQ;rghz nre;J}uk; 
¾ u~hkzp khj;jpiu 
¾ Nkfuh[hq;f khj;jpiu 
¾ uh[g+gjp khj;jpiu 
¾ etKyf;Fspif 
¾ nfsrpfh; Fok;G9 
¾ ke;jfhr khj;jpiu 
¾ kNdhrpiy urg;gjq;fk; 
¾ kNdhrpiy khj;jpiu 
¾ kNdhrpiy #uzk; 
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¾ kNdhrpiy vz;nza; 
¾ kNdhrpiy Gif 
¾ fhsfz;l Nkfehuhaz khj;jpiu 
¾ g+uzre;jpNuhjak;  
kNdhrpiy NrUk; ead kUe;Jfs;: 
¾ re;jpNuhjaf; Fok;G 
¾ eadNuhf khj;jpiu 
¾ Nuhgzpurf;fphpia 
¾ ruzhQ;rdk; 
¾ Kf;jhjpkfhQ;rdk; 
¾ NyfhQ;rdg;nghb 
¾ ead tpahjp khj;jpiu17 
kNdhrpiy NrUk; tp~KwpT kUe;Jfs;: 
¾ tp~f;Fok;G 
¾ tpilik 
¾ RLfhl;LkPl;lhd; Fok;G 
¾ jpUFijyk; 
¾ tp~kUe;J18 
 
eQ;Rf;FwpFzk; 
mRj;j kNdhrpiyapd; Njhlk;> gupfhuKk;: 
¾ mRj;j kNdhrpiyapdhy; the;jp> gpuik Kjypa mNdf tpahjpfs; cz;L 
gz;Zk;. 
¾ gRk; ghy;> Njd; ,itfisf; fye;J *d;W ehs; cl;nfhz;lhy; mRj;j 
kNdhrpiyapd; Njhk; ePq;Fk;. 
¾ kNdhrpiyapd; eQ;Rf;FwpFzk; jdpahf $wg;gltpy;iy mjdhy; 
nts;isg;ghlhzj;jpw;F $wpAs;stw;iw ,q;F vLj;Jf; nfhs;syhk;. 
eQ;Rf;FwpFzk;: 
¾ rpuq;F nfhg;Gsk; cz;lhjy;> if> fhy;> typj;Jf; Fuq;F igrhrq;fspd; 
tpuy;fisg;Nghyhjy;. 
¾ ehSf;F ehs; Kfj;jpy; tPf;fKz;lhjy;. 
¾ tha; frj;jy;> %f;Fj;jz;L tPq;Fjy;>Nky; tha; cjL Gz;zhjy;. 
11 
 
¾ thapy; xU tpj fspk;Gr;Rit cz;lhjy;> ePh; Ruj;jy;;. 
¾ jhfk;> ePuilg;G> %u;rpj;jy;> tpau;j;jy;> ifAq;fhYk; tpauj;Jj; jpkpu;j;jy;> 
Kjypa nfhba FwpFzk; fhZk;. 
eQ;R KwpT: 
 Vyk;> KRKRf;ifNtu; ,uz;Lk; rkmsT vLj;FJ FbePu; nra;J mjpy; 
nts;isr;ru;f;fiu> gbfhuk; Nrh;j;J ,U Ntisahf xU kz;lyk; 
rhg;gplNtz;Lk;.19 
! ! ! ! !  
 
 
  
12 
 
ARSENIC DISULPHIDIUM 
Eng: Realgar or Red orpiment; Arsenic disulphide; Sans: Manashila Red 
Orpiment is a deep orange-yellow colored mineral with formula As2S3 
 It is found in volcanic fumaroles, low temperature hydrothermal veins, and hot 
springs and is formed both by sublimation and as a byproduct of the decay of another 
arsenic mineral.20    
General 
Category Sulfide mineral 
Formula 
(repeating unit) 
As2S3 
Strunz classification 2.FA.30 
Crystal system Monoclinic 
Crystal class 
Prismatic (2/m) 
(same H‐M symbol) 
Space group P21/n 
Unit cell 
a=11.475(5), b=9.577(4) 
c = 4.256(2) [Å], β = 90.45(5)°; Z = 4 
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Identification 
Color Lemon-yellow to golden or brownish yellow 
Crystal habit 
Commonly in foliated columnar or fibrous aggregates; may be 
reniform or botryoidally; also granular or powdery; rarely as 
prismatic crystals 
Twinning   On {100} 
Cleavage  Perfect on {010}, imperfect on {100}; 
Tenacity  Sectile 
Moh  scale hardness  1.5 – 2 
Luster  Resinous, pearly on cleavage surface 
Streak  Pale lemon-yellow 
Diaphaneity  Transparent 
Specific gravity  3.49 
 
Historical uses 
Orpiment was traded in the Roman Empire and was used as a medicine in China 
even though it is very toxic. It has been used as a fly poison and to tip arrows with poison. 
Because of its striking color, it was of interest to alchemists, both in China and the West, 
searching for a way to make gold 
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PHYSICO- CHEMICAL PROPERTIES  
Chemical structure   - As2S3 
Molecular Weight   - 213.97 
Physical state at room temperature - Solid 
Colour     - Red – brown 
Odour     - None 
Viscosity    - NA 
PH   - NA 
Solubility    - Practically insoluble in water auto 
ignition temperature    - NIF 
Chemical interactions    - NIF 
Major products of combustion -       Sulphur dioxide gas and  
    Arsenic trioxide 
Explosive limits    - NA 
Flammability    - Ignites at high temperatures 
Boiling point   - 565 C 
Density    -  alpha 3.506 
    B 3.254 
Vapor pressure   - NIF 
Relative vapor density   - NIF 
Flash point   - NIF 
Reactivity    - No reaction with water. 
MEDICINAL USES 
¾  It is purified by being rubbed with the juice of lemons or ginger. It is used as an 
alternative, febrifuge and tonic, given in fever, cough, asthma and skin disease; in 
these last is used also externally. 
¾ Locally it is applied to fistulous sores  recommends for application to the eye, in 
affections of the internal tunics, tumors or other growths, night blindness etc., It is 
used as an alternative, febrifuge and tonic, given in fever, cough, asthma and skin 
disease; in these last is used also externally. 
¾ In fever it is generally used in combination with mercury, orpiment etc.., as in 
following: 
16 
 
¾ Chandesvara Rasa already mentioned under arsenious acid is recommended in 
Rasenrdrasarasangraha for remittent fevers. 
¾ Svasakuthara Rasa is another preparation mentioned in the same, and consisting of 
Reaglar, Mercury, sulphur, Aconite, Borax, Black pepper, Ginger And Long 
pepper, is Recommended is asthma with cough and in remittent fever with 
cerebral complications. Dose is 4 grains in pills form. 
¾ In coma from remittent fever, these pills are powdered and used as a snuff to rouse 
the patient. 
¾ A preparation known as chandraprabha  varti is made of realgar, gale, conch shell 
lime, seeds of Maringa pterygosperma, long pepper, liquorices and the kernel of 
belleric myrobalan in equal parts rubbed together with goat’s milk, dried and 
made in to small pastilles, these are rubbed with a little honey and applied the eyes 
as a collyrium.21 
¾ It is purified by being rubbed with the juice of time or ginger. It is used internally 
in fever, skin disease cough, asthma etc and externally in skin disease.  Realgar 
mixed with ashes of  (achyranthus aspera) is  used externally for leucoderma.1 
    
MISCELLANEOUS USES 
¾ Leather industry, 
¾ Depilatory agent 
¾ Paint pigment, 
¾ Shot manufacture, 
¾ Pyrotechnics, 
¾ Rodenticide 
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ARSENIC DISULPHIDIUM 
Introduction  
 Arsenic disulphide is a naturally occurring form of arsenic and is found as realgar, 
one othe major arsenic containing minerals.  Arsenic disulphide is insoluble in water and 
so poorly absorbed. It therefore represents a much less acute toxic hazard than soluble 
arsenic compounds. 
Type of product: 
  Insoluble arsenic compound found naturally as the ore realgar.  
Toxicokinetics   
Absorption 
 Insoluble compounds, such as arsenic disulphide, are poorly absorbed after 
ingestion. The efficiency of absorption is dependent on particle size; fine powders are 
better absorbed than larger particles. Following inhalation irrespirable particles are 
trapped in the upper airways and deposited in the gastrointestinal tract by mucociliary 
clearance. 
Distribution 
 Absorbed arsenic is distributed to all body tissues. High concentrations would be 
expected in keratin-rich tissues such as hair, skin and nails due to sulphydryl group 
binding. Trivalent arsenic is methylated in the liver to methylarsonic acid and 
dimethylarisinic acid. 
Excretion  
The half – life of arsenic in blood is about 60 hours with rapid renal excretion 
predominantly as mono – and dimethyl – detivatives and the whole body half – life of 
arsenic in six human. 
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Toxicity 
 Arsenic disulphide poisoning is rare.  Exposure may occur via ingestion of herbal 
remedies or in industry. Fatal dose not known. 
Features : 
Systemic toxicity may follow arsenic disulphide ingestion. Inhalation or topical 
exposure. 
Topical: 
Irritant to skin and mucous membranes. Systemic arsenic poisoning may occur 
after substantial exposure. 
Ingestion  
 Very small ingestion is likely to cause only mild gastro – intestinal upset. 
Substantial ingestions: 
¾ Rapid onset (within 1-2 hours) of burning of the mouth and throat, 
hypersalivation, dysphagia, nausea, vomiting, abdominal pain and diarrhea.  
¾ In severe cases gastrointestinal haemorrhage, cardiovascular collapse, renal 
failure, seizures, encephalopathy and rhabdomyolysis may occur. 
¾ Other features: facial and peripheral ocdema, ventricular arrhythmias (notably 
torsade de pointes), ECG abnormalitiy (QT interval prolongation, T- wave 
changes), muscle cramps. 
¾ Investigations may show anaemia, leucopenia, thrombocytopenia or evidence of 
intravascular haemolysis. 
¾ Death may occur from cardiorespiratory or hepatorenal failure.  The adult 
respiratory distress syndrome (ARDS) has been reported. 
¾ Survivors of severe poisoning may develop a peripheral neuropathy and skin 
lesions typical of chronic arsenic poisoning. 
Inhalation  
 Rhinitis, pharyngitis, laryngitis and tracheobronchitis may occur. Tracheal and 
bronchinal haemorrhage may complicate severe cases. 
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MODE OF ACTION: 
 Arsenic interferes with cellular respiration by combining with the sulphhudral 
groups of mitochondrial enzymes, especially pyruvate kinase and certain phosphatases.   
Arsenate causes it’s toxicity by uncoupling mitochondrial oxidative phosphorilation.  It 
interfers with glycolysis.  Its particular target is vascular endothelium, leading to 
increased permeability, tissue edema and hemorrhage (speciously in intestinal canal).  It 
causes irritation of the mucous membrances and depression of the nervous system. 18 
SIGNS AND SYMPTOMS OF ACUTE ARSENIC POISONING 
The symptoms usually appear within half an hour, they may be delayed for several 
hours (especially in parental route). 
The patient usually complaints of a feeling of tiredness, depression, nausea, fever 
burning pain, constriction in the throat and stomach which increases on pressure. Increase 
salivation and stomatitis may present.  Intense thirst and projectile vomiting are the 
constant symptoms. 
Gastro intestinal symptoms: 
¾ Resembles bacterial food poisoning 
¾ Sweetish metallic taste 
¾ Constriction in throat, difficulty in swallowing. 
¾ Projectile vomiting. 
¾ Purging (rice water stool). 
Renal : 
 The urine is suppressed or scanty and contains albumin, increased vascular 
permcability, ventricular tachycardia and ventricular fibrillation. 
Central nervous system: 
Headache, vertigo, hyperthermia, tremors, convolutions, coma, general, paralysis. 
Skin:  
 Delayed loss of hair, skin eruptions. 
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Other symptoms: 
¾ There may be severe cramps in the calf muscles, as well as other 
muscle, which usually commence in purging. 
¾ The patient becomes restless greatly dehydrated and passes in to a state 
of collapse.  The skin becomes cold and clammy, and the face is pale 
anxious but later becomes cyanosed. 
¾ The eyes are shrinken. 
¾ The pulse is feeble, irregular and frequent. The respiration becomes 
labored. Lastly hypoxic convulsions’ and coma proceed death.  
¾ When a large done is taken, the death may occur rapidly from shock 
without producing any symptoms. 
 
SUB ACUTE TYPE 
 It is usually result when arsenic is administered in small doses at repeated 
intervals to cause death by gradual prostration. The symptoms are dyspepsia, cough and 
tingling in the throat, followed by vomiting, purging with abdominal pain and tenesmus, 
foul tongue, dry, congested throat, feeling of depression and languor.  The stools are 
bloody.  The symptoms of neuritis are pronounced. Severe cramps in muscles, which are 
extremely tender on pressure.  Very restless and cannot sleep. 
 
CHRONIC ARSENIC EXPOSURE 
¾ May occur following ingestion, inhalation or topical exposure.  Features 
include weakness, lethargy, 
¾ Gastrointestinal upset, dermal manifestations (hyperkeratosis and 
“raindrop” pigmentation of the skin), a peripheral (motor and sensory) 
neuropathy and psychological impairment. 
¾ Also reported: peripheral vascular disease (cold sensitivity progressing to 
ulceration and gangrene), renal tubular or cortical damage and 
hematological abnormalities (notabl pancytopenia).23 
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TREATMENT 
(1) Emetics are not recommended 
(2) Freshly precipitated, hydrated Ferric oxide orally in small doses converts toxic 
arsenic to non toxic Ferric oxide. 
(3) B.A.L, 400 to 800 mg on firstday, 200 to 400mg on second and third day. 
(4) Penicillamine may be used with BAL.100 mg/kg daily upto 1 to 2 g. 
(5) Demulcents lessen irritation. 
(6) Castor oil or magnesium sulphate to prevent intestinal absorption of arsenic. 
(7) Hemodialysis or exchange transfusion may be given if necessary. 
(8) Chelation Therapy is ineffective in arsine poisoning. 
 
22 
 
RECENT RESEARCH 
1. The medicinal use of realgar (As2S3) and its recent development as 
an anticancer agent. 
Wu J1, Shao Y, Liu J, Chen G, Ho PC. 
Arsenicals have been known as poisons and paradoxically as therapeutic agents. 
In the early 1970s, Chinese physicians from Harbin revived the medicinal use of 
arsenicals as anticancer agents. Notable success was observed in the treatment of acute 
promyelocytic leukemia (APL) with arsenic trioxide (ATO). The FDA approved ATO 
injection in the year 2000 for the treatment of APL. In contrast, the clinical use of the 
other arsenical, realgar (As₄S₄), is currently much less established, though it has also long 
been used in medical history. According to ancient medical records and recent findings in 
clinical trials, realgar was found as effective as ATO, but with relatively good oral safety 
profiles even on chronic administration. These give realgar an advantage over ATO in 
maintenance treatment. Though there is increasing understanding on the mechanisms of 
action and metabolic profiles of ATO, similar aspects of realgar are unclear to date. Biol 
Pharm Bull. 2013;36(4):641-8. Epub 2013 Jan 25. 
2. Reversal effect of arsenic sensitivity in human leukemia cell line 
K562 and K562/ADM using realgar transforming solution. 
Wang X1, Zhang X, Xu Z, Wang Z, Yue X, Li H 
The success of arsenic trioxide (ATO) in treatment of acute promyelocytic 
leukemia (APL) attracts a great deal of attention to researchers to explore its activity of 
anti-leukemia. However, ATO has unavailable effect on chronic myeloid leukemia 
(CML), especially multidrug resistant (MDR)-CML, unless using high concentration. 
Realgar (As(4)S(4)) has been employed in Chinese traditional medicine for 1500 years. 
Research evidences confirmed realgar has similar effect on treating with APL as ATO, 
but the problem of large dose and long period in the CML/MDR-CML treatment still 
exist. By using a microbial leaching process with Acidithiobacillus ferrooxidans, we 
obtained realgar transforming solution (RTS) which showed significantly higher extent in 
inhibiting CML cell line K562 and MDR-CML cell line K562/ADM, and then trigger 
apoptosis. Both K562 and K562/ADM showed arsenic-dose-dependent effect on RTS. 
Interestingly, the overexpression of MDR1 mRNA and P-glucoprotein (P-gp) in 
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K562/ADM cells were down-regulated by RTS, where there are no obvious effects on 
ATO and realgar and arsenic can be subsequently accumulated in K562/ADM cells 
efficiently. The intracellular accumulation of arsenic in K562/ADM cells treated with 
RTS for 4 h was 2-fold and 16-folds higher than those treated with realgar or 
ATORealgar-induced apoptosis and differentiation in all-trans retinoic acid (ATRA)-
sensitive NB4 and ATRA-resistant MR2 cells 
3. Realgar-induced apoptosis and differentiation in all-trans retinoic 
acid (ATRA)-sensitive NB4 and ATRA-resistant MR2 cells 
Realgar has been used in Western medicine and Chinese traditional medicine 
since ancient times, and its promising anticancer activity has attracted much attention in 
recent years, especially for acute promyelocytic leukemia (APL). However, the 
therapeutic action of realgar treatment for APL remains to be fully elucidated. Cellular 
cytotoxicity, proliferation, apoptosis and differentiation were comprehensively 
investigated in realgar-treated cell lines derived from PML-RARα+ APL patient, 
including the all-trans retinoic acid (ATRA)-sensitive NB4 and ATRA-resistant MR2 cell 
lines. For analysis of key regulators of apoptosis and differentiation, gene expression 
profiles were performed in NB4 cells. Realgar was found to induce apoptosis and 
differentiation in both cell lines, and these effects were exerted simultaneously. Gene 
expression profiles indicated that genes influenced by realgar treatment were involved in 
the modulation of signal transduction, translation, transcription, metabolism and the 
immune response. 
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nts;shl;L %j;jpuf; Fzk;. 
“NrhignahL ghz;Litj;J uj;Jk; gytPf;f 
jhgkfw; Wk;Kjpuj; ijg;Nghf;Fk; - NfhgKld; 
cs;shl;Lj; Jh;r;rijNah Nlhq;Fju Nehafw;Wk; 
nts;shl;L %j;;jpuk;tp iue;J” 
 (ngh-iu) nts;shl;L %j;jpuk; Nrhig> ghz;L> gw;gy tPf;fj;jpndhpr;ry;> 
,uj;jg;Nghf;F> Jh;khkprk;> kNfhjuk;> ,itfis ePf;Fk;.19 
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URINE 
 In this modern era people have tried many ways to solve disease problem and find 
new cure that is more effective than the conventional medication. Some medication ways 
is maybe seems weird for certain people but some others believed that those ways are 
effective to be done.  
 One of unique healing method that human ever experienced is urine therapy or 
also known as urotherapy. Maybe its sound unbelievable but yes, its happen and being 
used by several person to overcome several health problem. 24 
HISTORY 
           Though urine has been used for diagnostic and therapeutic purposes in several 
traditional systems, and mentioned in some medical texts, auto-urine therapy as a system 
of alternative medicine was popularized by British naturopath John W. Armstrong in 
early 20th century. 
Armstrong was inspired by his family's practice of using urine to treat minor 
stings and toothaches, by a metaphorical reading of the Biblical Proverb 5:15 "Drink 
waters out of thine own cistern, and running waters out of thine own well", and his own 
experience with ill-health that he treated with a 45-day fast "on nothing but urine and tap 
water".  
Starting in 1918, Armstrong prescribed urine-therapy regimens that he devised to 
many thousands of patients, and in 1944 he published The Water of Life: A treatise on 
urine therapy, which became a founding document of the field. 
MEDICINAL PROPERTIES OF URINE 
¾ It may sound strange but urine’s medicinal properties were discovered by 
our ancient stages.  Charak samhita has described the role of urine in 
anointing, pasting, enema, purgatives, fomentation and abdominal 
distension. 
¾ Urine is used in poisoning also. 
¾ Urine endowed with properties of being sharp, pungent, saline and non 
unctuous is useful in diseases 
¾ Urine promotes appetites and digestion.  
¾ Urine acts as anti poison and kills worms in the body.   
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¾ Urine gives appreciable results in anemia.  Ayurvedic texts have described 
properties of eight types of urine.   
¾ Urine is used in the form of internal application by drinking and through its 
external application by mixing it with some powered drugs. 
 
      GOAT’S URINE 
Animal urine and dung actually have quite long histories as medicinal.  In fact, 
urine was probably one of the few truly sterlile liquids available during the golden age of 
piracy (although the need for sterility was not actually understood at this time. 
Some people claim that urine is actually a wonderful natural medicine 
As Martha Christy details, a person’s “Urine is an enormous source of vital 
nutrients, vitamins, hormones, enzymes and critical antibodies that cannot be duplicated 
or derived from any other source.  
 
URINARY PARAMETERS IN GOAT’S URINE25 
Colour Pale yellow, dark brown 
URINE VOLUME 10-40ml/kg 
SPECIFIC GRAVITY 1.020-1.040 
ODOUR clear indifferent aromatic 
PH 7.5 -8.5 
PROTEIN Negative 
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USES OF GOAT URINE                       
¾ Healing cancer 
¾ Heart disease 
¾ Allergies 
¾ Auto-immune disease 
¾ Diabetes 
¾ Asthma 
¾ Infertility 
¾ Infections, wounds and on and on. 
The usually staid Robert James has the most to say on this particular topic.  He 
advises his readers that goat’s urine “is recommended above say on this particular topic.22 
He advises his readers that goat’s urine “is recommended above that of all other 
Animals for dissolving the Stone [kidney and urinary tract stones], and promoting a 
discharge of Urine; for which Reason it is proper in a Dropsy.  (Dropsy – an 
accumulation of fluid under the skin – is often accompanied by poor urine flow.)  He goes 
on to suggest using the goat’s urinary bladder can be “dry’d and reduced to a Powder 
“because” it is said to be a medicine of peculiar Efficacy in an Incontinence of Urine26”. 
 
OTHER USES OF GOAT’S URINE 
The goat’s urine is gently heated and filtered, when it is given at the doses of 1 – 
1½ oz.  in Nardostachys grandiflora (sodamanjil), it controls epilepsy.7 
 
GOAT URINE IN AYURVEDA 
  Goat urine is used for its medicinal benefits in Ayurveda. It is used both for oral 
consumption and external application in itchy skin disorders, Tinea infection etc. 
 Urine of the goat is astringent, sweet, whole some and balances all the three 
Doshas 
 Goat urine is used as liquid binding agent in Vilwadi Gulika. It is used in treating 
scorpin bite, rhodent bite etc. 27 
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Goat urine for external application: 
             Goat urine is applied externally for, itching skin diseases, ringworm, 
dermatophytosis or tinea infection, Herpes, spreading skin diseases 
Mustard oil cooked with 4 times of goat urine is useful for massage for a patient suffering 
from epilepsy. 
 
Usage in uterine disorders 
              Medicated bougie is prepared of Saussurea lappa, Piper longum, buds of 
Calotropis gigantea and rock salt by triturating with goat’s urine. It is kept inserted into 
the vagina which cures Karnini type of uterine diseases. All the therapeutic measures 
prescribed for the treatment of diseases caused by kapha are also beneficial for the cure of 
this ailment.  
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RECENT RESEARCH 
1. P-Ethylphenylsulphuric Acid in Goat Urine 
BY J. K. GRANT, Department of Biochemi8try, UniverBity of Edinburgh 
(Received 13 April 1948) 24 
Although it was suggested by Baumann in 1879 that p-ethylphenol might be 
formed in the animal body by the degradation of tyrOsine, the presence of this substance 
was not reported until 1927, when Walbaum & Rosenthal (1927) and Pfau (1927), 
isolated it from the dried scent glands of the beaver.More recently, Lederer (1943, 1946) 
isolatedp-ethylphenol from an extract of acid-hydrolyzed pregnant mare urine. In the 
presentwork the isolation ofp-ethylphenylsulphuric acid from urine as the potassium salt 
is reported for the first time. This substance was initially obtained from the urine of an 
ovariectomized goat, which had received large doses of progesterone and hexoestrol. 
Subsequently it was also isolated from the urine of a normal goat. In view of the belief 
(Williams, 1947) that p-cresol is quantitatively the most important phenol in the urine of 
vertebrates, it is noteworthy that no clearcut evidence has been obtained for the presence 
of p-cresyl sulphuric acid in the urine exanmined. The fact that the derivatives ofp-
ethylphenol, prepared from the hydrolysis product of the sulphate, required frequent 
recrystallization before constant melting points could be obtained, might suggest that the 
isolated substance was contaminated with appreciable amounts of the sulphate of p-cresol 
or of other phenols. Nevertheless, the present work indicates that in the goat p-
ethylphenylsulphuric acid is excreted in larger amount than p-cresylsulphuricacid. 
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2.  Cerebral sodium/angiotensin interaction studied by RIA-
determination of urinary arginine vasopressin in the hydrated goat. 29 
Lishajko F, Appelgren B, Eriksson S. 
Radioimmunoassay determination of urinary arginine vasopressin (AVP) was 
employed to study quantitatively cerebral Na+/angiotensin II (A II) interaction in the 
hydrated goat. The solutions infused for 30 min at 0.02 ml/min into the lateral cerebral 
ventricle were: a) Hypertonic (0.25 M) NaCl, b) AII (0.3 ng/kg min) in isotonic (0.15 M) 
NaCl, and c) A II (doses as in b) in 0.25 M NaCl. The mean amounts of AVP detected in 
the urine in response to the various infusions were: a) 2.8 ng, b) 3.6 ng, and c) 13.3 ng. 
Thus, the A II/NaCl stimulation induced a detected renal excretion of AVP that was two 
times as large as the sum of the effects recorded in response to separate stimuli. Infusion 
c) invariably induced a pronounced, long-lasting inhibition of the water diuresis, intense 
thirst, and natriuresis. The corresponding effects of infusions a) and b) were much weaker 
and, as regards thirst and natriuresis, inconsistent. The determinations of renal AVP 
excretion provide additional and rather direct evidence for the concept of a synergistic 
action of elevated cerebrospinal fluid [Na+] and A II as concerns cerebral control of fluid 
balance. With regard to this kind of interaction, the observed dipsogenic and natriuretic 
effects mainly confirm earlier observations. 
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cSe;J 
BOTANICAL NAME: 
 Vigna mungo (Lion) Hep 
NtW ngah;: 
¾ cSe;J 
¾ khlk;  
¾ kh~k; 
VERNACULAR NAME: 
Eng.             Black gram  
 Tel.  Minumu  
Mal.              Ulunnu  
 Sans.  Masha  
 Kan.   Uddu  
 Hind.  Masha 
,/J ,e;jpahtpnyq;Fk; gapuhFk; xUtifr; nrbapd; tpij.31 
 
gad;gLk; cWg;G:  
¾ tpij> 
¾ Nth; 
Rit 
 ,dpg;G>  
jd;ik  
 jl;gk;>  
gphpT  
 ,dpg;G. 
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tiffs; 
rpW cSe;J 
ngU cSe;J 
vd ,Utifg;gLk; ,tw;Ws; rpwpaJjhd; rpwe;jJ. ,jidf; nfhopj;Jf; fy; 
kz; Kjypaitfis ePhpy;> ed;whf cyh;j;jpg; gpwF rpwpJ ey;ntz;nzia 
cSe;jpd; kPJ gLk;gb (mjpf vz;nza; Njitapy;iy) ed;whff; Nfhjp> 
fy;ae;jpuj;jpypl;L ,uz;b uz;L gpsthFk;.  gb cilf;fTk;. gpwF cuypypl;Lf; 
Fj;jp nghl;il ePf;fpg; gUg;ig vLj;Jg; gy gz;lq;fSf;Fk; cgNahfg;gLj;jyhk;.  
,/J ,dpg;Gr; RitiaAk;> nea;g;G> fdk;> c~;zk;>thj klf;fp> Kjypy; 
Fzq;fisAk; ngw;Ws;sJ.32  
 
nra;if: 
¾ cs;soyhw;wp   
¾ Fsph;r;rpAz;lhf;fp   
¾ fhkk;ngUf;fp   
¾ ghw;ngUf;fp   
¾ cukhf;fp   
¾ clYukhf;fp   
nghJ Fzk;:  
,/J czTg; nghUl;fSs; xd;W. kpFe;j mstpd; cz;zpy;> 
tapw;Wf;fLikAz;lhfp> grpj;jPiaf; nfLf;Fk;.  clw;F Cl;lj;ijAk; moifAk; 
nfLf;Fk;.> ngz;fSf;F ,Lg;Gf;F typikiaj; jUk;.> clYf;Ff; 
Fsph;r;rpiaj;jUk24 
nra;aTcSe; jpw;Fr; rpNyj;ktdp yw;gpwf;fk; 
nta;agpj;jk; Nghke;jk; tPWq;fhz;- nka;ajdpy; 
vd;GUf;fp jPUk; ,Lg;Gf; fLgykhk; 
Kd;G tpUej;jpAz;lha; Kd;.25 
t-F : cSe;ij khthf;fpg; gz;lq;fshf nra;J mUe;j td;ik jUk;. 
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cSe;Jtil 
,ijr; rhg;gpLtjhy; tspf;Fw;wk; kpFk;> grp nfLk;.  Fsph;r;rpAWk;. 
  ‘ntWKSe;jpw; nra;tilf;F Nkd;NkYk; - thjk; 
  cWk;gpj;jk; rw;Nw nahLq;Fk; - eWj;jP 
  gzk;Nghk; Grpg;gp;w; gUfed;wk; thyp 
  adk;Ngh zilah awp.’ 
cSe;Njhjdk; 
¾ ,J ke;jk; cz;lhFk;: 
¾ ,J Iaj;ijAk; tspf;Fw;wj;ijAk; ngUf;Fk;: 
¾ jPf;Fw;wj;ijj; jd;dpiyg;gLj;Jk;> 
¾ clk;ig tYf;fr; nra;Ak;. 
“vQ;Rfg thjkpf VWkjp ke;jKWk; 
tpQ;Rgpj; je;jhK nka;Auf;Fk; - mQ;rk; 
vKe;Njhjk; Gf;F kpdpaeil khNj 
cSe;Njh jdj;jpw; Fiu.” 33 
 
cSe;jpd; gad;fs; :
 
¾ gr;ir cSe;J khitj; Njd; Nrh;j;J mUe;jyhk;. 
¾ cSe;ij ePhpy; Cwitj;J vLj;j ePiu> kWehs; mjpfhiyapy;  
        mUe;j *j;jpu rk;ge;jkhd tpahjpfs; Nghk;. 
¾ ,ijf; nfhz;L nra;fpw vz;nza;> tspNeha;> Klf;F Neha;fs;   
        Kjypatw;wpw;F NehAs;s ,lj;jpy; g+rptu mit Nghk;. 
¾ Ntiu miuj;Jf; #lf;fp tPf;fq;fSf;F itj;Jf;fl;lyhk;. 
¾ cSe;ij tilahfr; nra;Jk;> fQ;rpahf; fha;r;rpAk; cz;fpd;wdh;.   
        ,jdhy; ,isj;j cly; gUf;Fk;.  cSe;J til td;ik  
        cz;lhk;. 
¾ ngUk;ghYk; ,jid ePhpy; Cwitj;J Ml;Lf; fy;ypy; Ml;bj;jhd;  
  ,l;bypf;Nfh> tilf;Nfh> kw;wg;gzpahuq;fSf;Nfh   
  cgNahfg;gLj;Jfpwhh;fs;. 
¾ ,Lg;Gf;F cWjpahifahy;> ,jid tWj;J khthf miuj;J>  
        rh;f;fiu nea; ,l;L cf;fspahff; fpz;bg; ngUk;ghd;ikAk;  
        G~;gtjpahd ngz;fSf;Ff; nfhLg;gJ tof;fk;. 
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¾ ,jid milahfr; nra;J cz;z> thjhjpf;fkhFk;. gpj;j NfhgKk;>  
        cjpuhf;fpdpAk; nfLk;.  Mdhy; cz;b NahL tiliaj; jpd;J ed;W. 
cSe;j gUg;gpd; Fzk;: 
  'cSe;jpd; gUg;ig Ayh;j;jpa+ wr;nra; 
  jOe;jh jiuj;Jtil ahf;fpr; - nrOe;Njdpw; 
  $l;bAs;s itagpj;j NrhigaWk; Cdijapiy 
  jPl;baNtw; fz;khNj Njh;.' 
 Gspj;j japhpy; cSj;jk; gUg;ig Cwitj;Jg; ngUgbahf miuj;Jg; 
ghfkhfr; Rl;l tilia ey;y Njdpy; Njha;j;J cz;zpy;.  gpj;j 
rpNy~;kNuhfq;fs; mWk;.  thj Njh~k; tpUj;jp MfhJ.   
 Ngad; thiog;goj;ijr; Nrh;j;Jr;> nra;j cSj;jk; tilia nea; njhl;L 
cz;z.  thjgpj;j Njhlq;fs; jj;jk; epiyapy;epw;Fk;. 
“Ngad; fjypgok; nga;jkh ~j;jpd;til 
NeaKw mikj;J epj;jKNk - NeaKld; 
jhdUe;jpy; thjgpj;je; jj;jk;epiy nfhz;lkUe; 
NjdUe;jhj; NjNd njsp.” 
cSe;jpd; kUj;Jtg; gad;fs;: 
¾ cSe;ij khthf;fp> mjDld; kpsF> rPufk;> nfhj;jky;yp kQ;rs; 
Mfpatw;iwr; Nrh;j;J miuj;J fQ;rp fha;r;rp Fbj;jhy;> Fly; Gz;fs; 
MWk;. 
¾ cSe;J> ghh;yp – jyh 100 fpuhk;> kpsF> rPufk;> g+z;L kQ;rs; - jyh 
gj;J fpuhk; vLj;J miuj;J> fQ;rp fha;r;rp Fbj;jhy; ntl;ilr;#L> 
nts;isg;gLjy; Nghd;wit FzkhFk;. 
¾ cSe;J khT> jpiz khT - ,uz;ilAk; rk msT vLj;J Njdpy; 
Fioj;Jr; rhg;gpl;L te;jhy;> cly; ,Uk;igg;Nghy; cWjpahFk;. 
¾ cSe;ijj; jz;zPhpy; Nghl;L Cwitj;J> kWehs;> fhiyapy; me;jj; 
jz;zPiuf; Fbj;jhy; rpWePuf Neha;fs; midj;Jk; FzkhFk;. 
¾ cSe;J> rpd;d ntq;fhak; - ,uz;ilAk; Nrh;j;Jk; fQ;rp fha;r;rpf; 
Fbj;jhy;. Mz;ikf; FiwT ePq;Fk;. 
¾ cSe;J> rpW gUg;G> gr;rhprp – Kd;iwAk; Nrh;j;J fha;r;rp Fbj;jhy;> 
ghY}l;Lk; ngz;fSf;F ghy; Ruf;Fk;  
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Adhdp Kiw 
¾ cly; nropf;Fk;> jhJ tpisAk;> ,Lg;Gf;Fg; gyk; nfhLf;Fk;. 
¾ ke;jpf;Fk;> kyr;rpf;fy; cz;lhFk;> fhw;iw cz;lhf;Fk; tapW           
cg;Gk;. 
khw;W :  nea;> [Puz gjhh;j;jk;. 35 
eQ;Rf; FwpFzk; :  
,ij mstwpe;J cz;zpy; clk;gpw;F Cl;lj;ijAk; moifAk; 
nfhLf;Fk;. mstpw;F mjpf mstpy; cz;zpy; grpj;jPiaf; nfLj;J mrPuzj;ij 
cz;lhf;Fk; tapw;Wf;fLg;Gk;> tapW gSTk; cz;lhFk;.   
kyr;rpf;fyhtJ> fopr;ryhtJ fhZk; neQ;Rf; fhpg;G Vw;gLk;. 
 
KwpT 
Njitahd nghUl;fs; : (1) 4 fpuhk; nfhs;Sf; fha; Ntis> (2) 4 fpuhk; 
kpsF> (3) 4 fpuhk;; rPufk;> (4) 4 fpuhk; Njd;. 
nra;Kiw : nfhs;Sf;fha; Ntis> kpsF> rPufk; Mfpa Kd;W ruf;FfisAk; 
Nkw;nrhd;d mstpd;gb vLj;J ,bj;J kz;rl;bapypl;L> 165 kp.ypl;> ePh;tpl;L 
fhyhohf;fhff; fha;r;rp mj;Jld; 4 fpuhk; Njd;.  Nrh;j;J td;ikf;Fj; jf;f 
ehssT nfhLf;f cSe;jpdhy; cz;lhd eQ;R Ntfk; jzpAk;.19  
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BLACK GRAM 
BOTANICAL NAME 
(Phascolus mungo Linn.) 
FAMILY 
Fabaceae 
VERNARCULAR NAMES: 
Eng     :   Black gram 
Hin     :   Urd 
Kan    :  Uddu 
Mal    :   Ulunnu 
San    :   Masah 
Tam  :    Ulunthu (cSe;J)!
Tel     :   Uddulu, Minumulu, Nallaminumulu. 
 
DISTRIBUTION:  
Cultivated all over India 
The Plant: An erect hairy annual with long twining branches, leaves trifoliate, 
leaflets ovate, Entire; flowers small, yellow on elongating peduncles; fruits cylindrical 
pods, hairy with a short, Hooked beak; seeds 1-4 per pod, generally black with a white 
hilum protruding from the seed. 
 
 PARTS USED:    
¾ Roots 
¾ Seeds 35 
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 DESCRIPTION 
Black gram (Vigna mungo (L.) Hepper) is an erect, fast-growing annual, 
herbaceous legume reaching 30-100 cm in height. It has a well-developed taproot and its 
stems are diffusely branched from the base.  
 Occasionally it has a twining habit and it is generally pubescent. The leaves are 
trifoliate with ovate leaflets, 4-10 cm long and 2-7 cm wide. The inflorescence is borne at 
the extremity of a long (up to 18 cm) peduncle and bears yellow, small, papilionaceous 
flowers. 
 The fruit is a cylindrical, erect pod, 4-7 cm long x 0.5 cm broad. The pod is hairy 
and has a short hooked beak. It contains 4-10 ellipsoid black or mottled seeds). 
Many Vigna mungo cultivars exist, each one adapted to specific environmental 
conditions.  
Vigna mungo seeds are mainly a staple food and the dehulled and split seeds . 
They can be ground into flour and used for making papadum, a typical Indian flat bread). 
Seeds, sprouts and green pods are edible and much appreciated for their high digestibility 
and lack of flatulence induction. 
DISTRIBUTION  
Vigna mungo originated from central Asia and India from where it was 
domesticated. It is now found in many tropical areas of Asia, Africa and Madagascar. It is 
cultivated in the USA and Australia as a fodder crop. It is generally found in lowlands but 
can grow up to 1800 m above sea level provided there is neither frost nor prolonged 
cloudiness. Optimal growth conditions are average day temperatures ranging from 25°C 
to 35°C and annual rainfall of 600-1000 mm. 
CULTIVATION DETAILS 
A plant of the drier tropics, where it is found at elevations up to 2,000 metres. It 
grows best in areas where annual daytime temperatures are within the range 22 - 35°c, but 
can tolerate 8 - 40°c 
The plant does not tolerate frost. It prefers a mean annual rainfall in the range 650 
- 900mm, but tolerates 530 - 2,430mm 
 Rain at flowering time has a very adverse effect upon seed yields 
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Plants are not adapted to wet, humid areas with high rainfall, but can, however, be 
grown in the dry season of wetter areas so long as this is at least 4 months in duration. 36 
CHEMICAL CONSTITUENTS  
Seed 
¾ y-glutamyl-y- glutamylmethionine,  
¾ Aalanine   
¾ L-pipecolic acid, 
Seed coat  
¾ Vitexin 
¾ β sitostaerol  
Seed protein 
¾ Cystine  
¾ Methionine 
¾ Valine 
¾ Isoleucine 
¾ Phenylalnine 36 
 
NUTRITIONAL VALUE OF BLACK GRAM 
Vigna mungo is a nutritious bean that is rich in protein, dietary fiber and 
carbohydrates.  Around 25% of its weight includes various proteins.  Every 100 gram of 
urad dal offers, 18 gm (72%) of dietary fibers, 1 gm of potassium (8%) and only 2gram of 
fat. 
PROPERTIES AND USES:  
¾ The roots are narcotic and are used for ostalgia, abscess and inflammations.  
¾ Seeds are sweet, emollient, thermogetic, diuretic, aphrodisiac, tonic, 
nutritious, galactagogue, appetizer,  
¾ Laxative and nervine tonic.  They are useful in dyspepsia, anorexia, strangury, 
constipation, vitiated 
¾ Conditions of vata, haemorrhoids, hepatopathy, neuropathy and agalactia.  
They are used in the form of decoction, powder, paste etc. 
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¾ The roots are narcotic and are used for ostalgia, abscess and inflammations.  
¾ In traditional medicine, the seed is used for its suppurative, cooling and 
astringent properties. For example, it is ground into a powder, moistened and 
applied as a poultice on abscesses. 
 
TRADITONAL USES: 
Black gram and skin benefits 
Apart from being used as a culinary ingredient, black gram also finds use in 
beauty cared because of its skin nourishing and rejuvenating properties. It offers immense 
benefits in maintaining a healthy and glowing skin.  It provides moisturization to your  
skin and keeps it soft and supple. or vitiligo 
 
 Digestive Disorders 
  A decoction obtained by boiling black gram in water is effective in treating 
indigestion and other digestive disorders like diarrhea, dysentery and dyspepsia. 
 
Black gram keeps healthy 
 Black gram has been found to be beneficial in boosting the health of your heart.  
The fiber in this lentil is effective in reducing cholesterol and the potassium helps to 
balance the effects of sodium, thus helping in lowering high blood pressure.  Studies also 
show that black gram can help reduce lipids and cholesterol in body.  These black seeds 
have ability to inhibit process of absorption of lipids and cholesterol. 
 
Black gram boosts energy 
 If you are constantly suffering from fatigue and tiredness, including black gram in 
your diet can help you become active.  The high amount of nutrients like iron in this lentil 
raises your energy levels and keeps your active for a very long time. 
Black gram has Anti-inflammatory properties 
Ayurvedic medicine considers black gram as an excellent remedy for treating 
inflammation and joint pain owing to its potent anti-inflammatory properties.  A hot 
poultice of this lentil placed on the affected area will help in relieving the inflammation 
and pain associated with it.   
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Black gram Increases Immunity 
 While being used as popular lentil, its use has been common in traditional 
Ayurveda where it has been used to treat various diseases.  It is traditionally believed to 
be food which increases immunity. 
Black gram for Pain and Inflammation of the points – 
 A decoction obtained by boiling black gram with rock salt and sesame oil, when 
applied to the affected areas in found to be beneficial in reducing pain and inflammation.  
This is particularly helpful for people suffering from joint pain and arthritis. 
Vigna mungo and Male Reproductive health  
 According to Ayurvedic medicine, Vigna mungo has aphrodisiac properties and 
helps in increasing the count and motility of sperms.  It is also found to be good for 
treating premature ejaculation and erectile dysfunction.  This is traditional home remedy 
for increasing the sperm count in males- heat some ghee (Clarified butter) and fry 
black gram in it, until it changes to light brown color.  Let it cool and then blend the fried 
lentil to a find powder.  It is also useful in treating erectile dysfunction and improving 
sexual potency. 
Vigna mungo for Diabetic patient 
 Vigna mungo is a good food option for people suffering from diabetes as it is rich 
in fiber.  A diet containing high amounts of fiber helps in controlling blood sugar levels 
and prevents spikes in these levels especially after a meal.  A wonderful home remedy for 
diabetic patients to keep their blood sugar levels under control is to take black gram 
(germinated) along with half a cup of bitter gourd once a day for about four months. 
Vigna mungo health benefits for Bones 
 Black gram is rich in proteins and minerals like calcium, phosphorus and 
magnesium that promote the growth and maintenance of healthy and strong bones.  The 
nutrients in this lentil strengthens your bones and prevents conditions like osteoporosis, 
which is characterized by a decrease in bone density and bone mass, thus making your 
bones easily susceptible to breakage and fractures. 
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Black gram is good for Pregnant Women 
 Pregnant women are often advised to include black gram in their diet because of 
its high nutritional value.  Black gram is a rich source to iron, which is needed for the 
production of hemoglobin and increased blood circulation.  It is also high in protein, 
dietary fiber and nutrients like folic acid that is not only good for the expecting mother 
but also for the fetus as it helps in preventing birth defects. 
Other uses of black gramIn  
 Traditional Ayurvedic practice, black gram is used in treatment of various nervous 
system disorders including paralysis. 
   
42 
 
RECENT RESEARCH 
1.  Trypsin-chymotrypsin inhibitors from Vigna mungo seeds.38 
Cheung AH1, Wong JH, Ng TB. 
Three trypsin-chymotrypsin inhibitors were isolated from seeds of the black gram 
(Vigna mungo) with a procedure that entailed cation exchange chromatography on SP-
Sepharose, anion exchange chromatography on Q-Sepharose, ion exchange 
chromatography by fast protein liquid chromatography (FPLC) on Mono Q and Mono S, 
and gel filtration by FPLC on Superdex 75. Two of the trypsin-chymotrypsin inhibitors 
were adsorbed on the first four types of chromatographic media. All three inhibitors have 
a molecular mass of 16 kDa as judged by gel filtration and sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. The trypsin inhibitory activity of the inhibitors was 
attenuated in the presence of the reducing agent dithiothreitol. The remaining inhibitor 
was unadsorbed on SP-Sepharose but adsorbed on Q-Sepharose, Mono Q and Mono S. 
The protease inhibitors did not exert any inhibitory effect on hepatoma (Hep G2) and 
breast cancer (MCF 7) cells or antifungal action toward Botrytis cinerea, Fusarium 
oxysporum and Mycosphaerella arachidicola. Two of the inhibitors slightly inhibited the 
activity of HIV-1 reverse transcriptase, with an IC50 in the mill molar range. 
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SUDDHI 
 Siddha system of medicine emphasis, before going to medicine preparation every 
raw drug must be purified. The concept of   Shuddhi (purification) in Siddha is not only a 
process of purification / detoxification, but also a process to enhance the potency and 
efficacy of the drug . 
Purification of raw drug is a process aimed at both purification as well as 
concentration of the raw drug.It usually involves processes like cleaning, frying, soaking, 
and grinding until impurities are removed. 
 
FORENSIC TOXICOLOGY: 
Forensic Toxicology deals with the source, physical and chemical properties, 
absorption, fate, pharmacological and toxic actions, signs and symptoms in human 
beings, fatal dose, and fatal period of different poisons, laboratory investigations, 
diagnosis, treatment, and circumstances and other medicolegal aspects of different 
poisoning cases. 
 Drugs are natural or synthetic substances which are used to exert physiological or 
psychological effects in the consumer. 
 
SIDDHA TOXICOLGY: 
The Siddha literature insists that for any medicine preparation, the evil effects of 
the following are to be noted and weeded out primarily. It starts from purification. 
 
1. PORUT PAARVAI-PHYSICAL PURIFICATION: Assessing the worthiness 
of the substance: 
i) The substance should be ascertained whether it is a real one. 
ii) Whether it has been prepared afresh to be beneficial for the intended time 
and season. 
 
2. PORUT THUIMAI-CHEMICAL PURIFICATION: Assessing the purity of 
the substance: 
i) Whether it has been properly purified strictly 
ii) Whether the substance purified is qualified for consumption. 
iii) Whether the dosage is suitable for consumption. 
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iv) Whether the antagonist of substance is avoided 
v) Whether the diet regimen is followed 
vi) Even if it is a poisonous substance whether its beneficial effects have 
been retained 
It is our primary responsibility to protect our health by curing the disorders caused 
by the toxins of the substances as well as to prevent the occurrence of toxicity.38 
 
VARIOUS SUDDHI OR PURIFICATION PROCESS: 
1. Removing the outer skin (epicarp). 
2. Removing the inner nuts. 
3. Removing the cotyledons. 
4. Boiling with milk, cows urine, etc. 
5. Frying ordinarily, with cows ghee, etc. 
6. Soaking in Mothers milk, cows urine, herbal juices, etc. 
7. Pacing the raw drug inside another material and treating. 
8. Grinding with various juices. 
9. By Thula endiram  
i) immersed 
ii) Without immersed. 
10. By Pudam process 
11. Simply washing or removing dust. 
 
OBJECTIVES OF SUDDHI: 
1. To remove impurities, toxins present 
2. To enhance the brittleness 
3. To improve the potency and efficacy of the drug 
4. To enhance the synergistic effect through purification methods 
5. Transformation of the nonedible non-homogenous material to edible 
and beneficial homogenous material 
6. Alleviation of desired therapeutic qualities 
7. To prove the unique and favourable changes from physico-chemical changes 
for further application or benefits of drug. 
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Test drug collection 
Manosilai was procured from a well reputed indigenous drug shop at Chennai on 
10-2-2016 
Goat’s urine was collected from anverthikanpet village on 17-3-2017     
Ulunthu was procured from country Market shop at thambram on 12-2-2016 
Identification and authentication 
 The mineral drug was identified and authenticated by Pharmacologist in Siddha 
Central Research Institute (SCRI) Arumbakkam Chennai.) On 25-05-16 
The raw drug Ulunthu was Idenified and authenticated In Plant Anatomy 
Research centre, by Prof.P.Jayaram, Retd, professor, Presidency College Chennai-5 on 
17-02-2017 
Method of purification 
.I will go for purification procedures as per text after that Subjected to 
standardization procedures as per PLIM guidelines. 
Required materials 
 Manosilai  
 Goats urine 
 Black gram boiled water 
 Thola appliances                                                                                                                             
METHOD 
Manosilai is made into small pieces and make in to a bundle, The above bundle is 
boiled with goat’s urine by using thula appliances and then the bundle is take out and kept 
in black gram boiled water after that the bundle is opened and dried it.40 
                    
REFERANCE: AGATHIYAR VAITHIYA KAVIYAM  
PAGE: 600 
EDITION: 1994 
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VARIOUS STAGES OF PURIFICATION PROCESS 
OF MANOSILAI (ARSENIC DISULPHIDE) 
 
1. Unpurified Manosilai      2.  Goat’s Urine 
 
 
 
 
` 
 
 
 
3. Bundled Manosilai      4.  During Process                                 
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    5. Boiled Blackgram water           6.  Manosilai kept  in black gram boiled  water 
 
 
 
 
 
 
 
 
 
 
7. After purification      8. Purified Manosilai 
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QUALITATIVE ANALYSIS: 
1. PHYSICO-CHEMICAL ANALYSIS: 
The physico-chemical analysis was done at Centre for Advanced Research in 
Indian System of Medicine (CARISM), SASTRA University, and Thanjavur. 
The physico-chemical parameters were analyzed to evaluate the quality of the 
drug. Physico-chemical parameters are done for both unpurified and purified drug. 
Appearance:  
Colour: 
About 5gm of the drug were taken separately in clean glass beaker and tested for 
its color by viewing again an opaque back ground under direct sunlight. 
Odour: 
About 5gm of the drug were placed separately in 100 ml of beaker and tested for 
its odour by wafting the air above the beaker. 
Loss on drying at 105 C: 
A glass stoppered Petridish was weighed and has been dried under the same 
conditions to be employed in the determination. The specific quantity of sample was 
transferred to the dish, covered and accurately weighed. Then the sample is evenly 
distributed in the petridish. Then the stopper is removed and the loaded dish is placed in 
the drying chamber as directed in the monograph. The sample is dried to constant weight 
or till two consecutive weights remain within ± 0.5mg.After drying is completed, the 
sample is cooled in desiccators. The dish and the contents are weighed. 
 
 Loss in weight (g) × 100 
Loss on drying (%w/w) =                                    
    Mass of the sample (g) 
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Determination of pH: 
The pH meter was operated according to the manufacturers instructions. The 
apparatus was calibrated using buffer solutions, adjusting the meter to read the 
appropriate pH value corresponding to the temperature of the solution. The electrode is 
immersed in the solution being examined and the pH is measured at the same temperature 
as for the standard solutions. At the end of a set of measurements, the pH of the solution 
used to standardize the meter and electrodes was recorded. If the difference between the 
reading and the original value is greater than 0.05, the set of measurements must be 
repeated. All solutions and suspensions of substance being examined must be prepared 
using carbon dioxide - free water. 
Total Ash: 
About 2 to 3g accurately weighed taken from the ground drug is incinerated in a 
tared platinum or silica dish at a temperature not exceeding 650 ºC, until free from 
carbon, cooled and weighed. If a carbon free ash cannot be obtained in this way, the 
charred mass is exhausted with hot water, the residue is collected on an ash less filter 
paper, the residue and filter paper is incinerated, the filtrate is added, evaporated to 
dryness, and ignited at a temperature not exceeding 650ºC.The percentage of ash with 
reference to air-dried drug is calculated. 
     Mass of ash (g) × 100 
Percentage of total ash (%w/w) = 
     Mass of the sample (g) 
Acid Insoluble Ash: 
The ash obtained is boiled for 5 minutes with 25ml of dilute hydrochloric acid. 
The insoluble matter is collected in a Gooch crucible, or on an ash less filter paper, 
washed with hot water and ignited to constant weight. The percentage of acid-insoluble 
ash with reference to the air dried drug is collected. 
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Calculation: 
Percentage of water soluble extractive (%w/w) = Mass of the residue (g) × 100 × 100 
 
        Mass of the sample (g) × 25 
Water soluble extractive: 
5g of the coarsely powdered drug is macerated with 100ml of chloroform water in 
a closed flask for 24 hours. It is frequently shaked for first six hours and allowed to stand 
for eighteen hours. Then it is filtered rapidly, 25ml of filtrate is evaporated to dryness in a 
tarred flat bottomed shallow dish over a water bath. Dried at 105ºC, in an oven to 
constant weight and the dish is weighed. The percentage of water soluble extractive with 
reference to the air-dried drug is calculated. 
Calculation: 
Percentage of water soluble extractive (%w/w) = Mass of the residue (g) × 100 × 100 
 
Mass of the sample (g) × 25 
Alcohol soluble extractive: 
5g of the coarsely powdered drug is macerated with 100ml of ethanol, of specified 
strength (as specified in the monograph) in a closed flask for 24 hours. It is frequently 
shaked for first six hours and allowed to stand for eighteen hours. Then it is filtered 
rapidly, taking precautions against loss of ethanol25ml of filtrate is evaporated to dryness 
in a tarred flat bottomed shallow dish over a water bath dried at 105 ºC, in an oven to 
constant weight and the dish is weighed. The percentage of alcohol soluble extractive of 
the drug is calculated. 
Calculation: 
Percentage of alcohol soluble extractive (%w/w) = Mass of the residue (g) × 100×100 
 
Mass of the sample (g) × 25 
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2. CHEMICAL ANALYSIS: 
The  Chemical  analysis  was  done  at  Biochemistry  Lab,  National  Institute  of 
Siddha, Chennai-47.. 
Table no: 1 Procedure for Chemical analysis of unpurified and purified raw drug 
Manosilai  
Experimental procedures of Chemical analysis 
S.No EXPERIMENT OBSERVATION INFERENCE 
1.  Appearance of sample 
Dark Orange in 
colour 
 
2. 
Test for Silicate: 
a.  A little (500mg) of the sample is shaken well  
    with distilled water. 
b.  A little(500mg) of the sample is shaken well 
     with con. HCl/Con. H2So4 
No Sparingly 
soluble 
Absence of 
Silicate 
3. 
Action of Heat: 
A small amount (500mg) of the sample is taken 
in a dry test tube and heated gently at first and 
then strong. 
White fumes    
evolved 
Presence of 
Carbonate 
4. 
Flame Test: 
A small amount (500mg) of the sample is made 
into a paste with con. HCl in a watch glass and 
introduced into non-luminous part of the 
Bunsen flame. 
Bluish green flame 
appeared. 
Presence of 
Copper 
5. 
Ash Test:  
A filter paper is soaked into a mixture of sample 
and dil. cobalt nitrate solution and introduced 
into the Bunsen flame and ignited. 
No Yellow color 
flame appeared 
Absence of 
Sodium 
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Preparation of extract:  
5gm of Manosilai seed powder is weighed accurately and placed in a 250ml clean 
beaker and 50ml of distilled water was added with it. Then it was boiled well for about 10 
minutes. Then it was allowed to cool and filtered in a 100ml volumetric flask and made 
up to 100ml with distilled water. 
S.No 
EXPERIMENT OBSERVATION INFERENCE 
I. Test For Acid Radicals 
1 
Test For Sulphate: 
2ml of the above prepared extract 
is taken in a test tube to this added 
2ml of 4% dil ammonium oxalate 
solution. 
No Cloudy appearance 
present 
Absence of  
Sulphate 
2 
Test For Chloride:  
2ml of the above prepared extract 
is added with 2ml of dil.HCl is 
added until the effervescence 
ceases off. 
NO Cloudy 
appearance present 
Absence 
of Chloride 
3 
Test For Phosphate: 
2ml of the extract is treated with 
2ml of dil.ammonium molybdate 
solution and 2ml of con.HNO3. 
No Yellow precipitate 
present 
absence 
of  Phosphate 
4 
Test For Carbonate: 
2ml of the extract is treated with 
2ml dil. magnesium sulphate 
solution. 
Presence of cloudy    
appearance 
Presence 
Of  Carbonate 
 
5           
Test For Nitrate: 
1gm of the substance is heated 
with copper turning and 
concentrated H2SO4 and viewed 
the test tube vertically down. 
NoBrown gas is 
evolved 
absence 
of  Nitrate 
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6 
Test For Sulphide: 
1gm of the substance is treated 
with 2ml of con. HCL. 
NoRotten Egg 
Smelling gas is 
evolved 
Absence 
of  Sulphide 
7 
Test For Fluoride & Oxalate: 
2ml of extract is added with 2ml of 
dil. Acetic acid and 2ml 
dil.calcium chloride solution and 
heated. 
No Cloudy appearance 
Absence 
Of  fluoride and 
oxalate 
8 
Test For Nitrite: 
3 drops of the extract is placed on 
a filter paper, on that-2 drops of 
dil.acetic acid and 2 drops of 
dil.Benzidine solution is placed. 
No Characteristic 
changes present 
Absence 
Of  Nitrite 
9 
Test For Borate: 
2 Pinches (50mg) of the substance 
is made into paste by using 
dil.sulphuric acid and alcohol 
(95%) and introduced into the blue 
flame. 
No Bluish green color 
flame appeared 
Absence 
Of  Borate 
Test for Basic Radicals 
1 
 
Test For Lead: 
2ml of the extract is added with 
2ml of dil.potassium iodine 
solution. 
NO Yellow Precipitate 
is obtained. 
Absence  of Lead 
2 
 
Test For Copper: 
One pinch (50mg) of substance is 
made into paste with con. HCl in a 
watch glass and introduced into the 
non-luminuous part of the flame. 
Blue color       
precipitate is formed. 
 
Presence 
Of  Copper 
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3 
 
Test For Aluminum:  
   To the 2ml of extract dil.sodium 
hydroxide is added in 5 drops to 
excess. 
No Yellow color 
appearance 
absence 
of  Aluminum 
4 
 
Test For Iron: 
a. To the 2ml of extract add 2ml of 
dil.ammonium solution. 
b. To the 2ml of extract, 2ml 
thiocyanate solution and 2ml of 
con HNo3 is added. 
 
Brown precipitate is 
formed 
Red color  appearance 
 
Iron  present 
 
 
5 
Test For Zinc:  
To 2ml of the extract dil.sodium 
hydroxide solution is added in 5 
drops to excess and dil.ammonium 
chloride is added.  
Nonwhite precipitate 
is   formed 
absence of Zinc 
6 
Test For Calcium:  
2ml of the extract is added with 
2ml of 4% dil.ammonium oxalate 
solution. 
Cloudy appearance or  
white precipitate  
formation is present 
Presence 
Of  Calcium 
7 
Test For Magnesium:  
To 2ml of extract dil.sodium 
hydroxide solution is added in 
drops to excess. 
White precipitate is  
obtained 
Presence of 
Magnesium 
8 
Test For Ammonium: 
To 2ml of extract 1ml of Kessler’s 
reagent and excess of dil.sodium 
hydroxide solution are added. 
No Brown color is 
appeared 
Absence 
Of  Ammonium 
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9 
 
Test For Potassium: A pinch 
(25mg) of substance is treated with 
2ml of dil.sodium nitrite solution 
and then treated with 2ml of 
dil.cobalt nitrate in 30% dil.glacial 
acetic acid. 
 
 
No Yellowish 
precipitate is obtained. 
 
 
Absence 
of  Potassium 
10 
 
Test For Sodium: 
2 pinches (50mg) of the substance 
is made into paste by using HCl 
and introduced into the blue flame 
of Bunsen burner. 
No Yellow color 
flame appeared 
Absence 
of  Sodium 
11 
Test For Mercury:  
2ml of the extract is treated with 
2ml of dil.sodium hydroxide 
solution.  
Yellow precipitate is 
obtained 
 
Presence 
Of  Mercury 
12. 
Test For Arsenic:  
2ml of the extract is treated with 
2ml of dil.sodium hydroxide 
solution. 
Brownish red 
precipitate is obtained 
 
Presence 
Of  Arsenic 
Other constituents: 
1  
Test For Starch : 
2ml of extract is treated with weak 
dil.iodine solution  
 
No Blue color 
formation 
 
absence of starch 
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2 
Test For Reducing Sugar: 
5ml of Benedict's qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boil it for 2 minutes. The 
color changes are noted. 
 
Brick red color  
developed 
 
Presence of  
reducing sugar 
3 
Test For The Alkaloids: 
a. 2ml of the extract is treated with  
2ml of dil.potassium iodide 
solution. 
b. 2ml of the extract is treated with 
2ml of dil.picric acid. 
 
Reddish brown 
precipitation  appears 
Yellow precipitation 
appears 
 
Presence 
Of  Alkaloid 
 
4 
Test For Tannic Acid:    
2ml of extract is treated with 2ml 
of dil.ferric chloride solution. 
 
No Black precipitate is 
obtained 
 
Absence of 
Tannic acid 
5 
Test For Unsaturated  
compound    
To the 2ml of extract 2ml of dil. 
Potassium permanganate solution 
is added. 
No Potassium 
permanganate is  
decolourised 
 
Absence of 
unsaturated 
compound 
6 
Test For Amino Acid:       
2 drops of the extract is placed on 
a filter paper and dried well. 20ml 
of Biurette reagent is added. 
 
No Violet color is 
developed 
 
Absence 
of amino acids 
7 
Test For Type of Compound: 
2ml of the extract is treated with 2 
ml of dil.ferric chloride solution.  
 
No Specific color 
formation 
 
Phenols absent 
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QUANTITATIVE ANALYSIS: 
The following quantitative analyses were done at SAIF, IITM, Chennai. 
3.  ICP-OES: 
Perkin Elmer Optima 5300 DV was used for standard ICP-OES analysis. The 
Emission spectrometry is based on the principle that atoms or ions in an excited state tend 
to revert back to the ground state and in so doing emit characteristic wavelength and 
intensity of that light is proportional to the concentration of that particular element in the 
sample solution. ICP-OES is widely employed for the estimation of metals and metalloids 
at trace, minor and major concentrations. The elemental composition of a sample is often 
an important part of the information needed to assess its properties. 
 
 
 
 
 
 
 
 
 
 
 
 
Principle: 
In this technique, the high temperature plasma source atomizes the sample and 
excites the atoms resulting in emission of photons. The atoms of each element in the 
sample emit specific wavelength of light. The emission spectrum from the plasma is 
dispersed by an optical spectrometer, so that intensities of the individual wavelength can 
be measured. The number of photons emitted is directly proportional to the concentration 
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A SEM is essentially a high magnification microscope, which uses a focused 
scanned electron beam to produce images of the sample, both top-down and, with the 
necessary sample preparation, cross sections. The primary electron beam interacts with 
the sample in a number of key ways:- 
¾ Primary electron generates low energy secondary electron, which tend to 
emphasize the topographic nature of the specimen. 
¾ Primary electron can be backscattered which produces images with a high 
degree of atomic number (Z) contrast. 
¾ Ionized atoms can relax by electron shell-to-shell transitions, which lead to 
either X-ray emission or Auger electron ejection. The X-ray emitted is 
characteristic of the elements in the top few µm of the sample. 
¾ The SEM is carried out by using FEI-Quanta FEG 200-High Resolution 
Instrument. 
Resolution: 1.2 nm gold particle separation on a carbon substrate 
Magnification: From a min of 12 xs to greater than 1, 00,000X 
Application:  To evaluate grain size, particle size distributions, material homogeneity 
and inter metallic distributions.  
7. ESTIMATION OF PESTICIDE RESIDUE  
Pesticide value of sample 1 was estimated by means of AOAC 2007.01 by GC 
MS MS/LC MS. Pesticides are usually used in agriculture to increase the yield, improve 
the quality and to extent the storage life of food crops. These are the deposits of pesticide 
active ingredients, its metabolites or break down products present in same component of 
environment after its application, spillage or dumping. residue analysis gives the nature 
and level of chemical contamination with the environment and of its persistence.   
Sample preparation  
The acetate buffered Quenchers sample preparation method was applied. After 
homogenization with a house hold mill a15gm portion of the homogenized sample was 
weighed into a 50 ml polytetrafluro ethylene tube (PTFE) and 100ml of surrogate 
standard solution in acetonitrile was added followed by 15 ml of aceto nitrile containing 
1% acetic acid. Then 6gm of MgSO4 and 2.5 gm sodium acetate trihydrate were 
added.then centrifuge the sample at 4000rpm. Then transferred the supernatant and 
62 
 
filtered with PTFE filter. Then sample was transferred to auto sample vials and the 
extracts were evaporated to dryness under a steam of Argon. The analysis done by gas 
chromatography.liquid chromatography coupled to tandem mass spectroscopy with triple 
quadruple mass analysers GC MS MS/LC MS. 
8. DETERMINATION OF MICROBIAL LOAD 
The determination of microbial load as described below was crried out on sample 
1 and 4 as per the WHO guidelines (Anonymous 1998). 
Pre-treatment of the test material: 
Depending on the nature of the crube herbal material grind, dissolve, dilute, 
suspend or emsulsify it using a suitable method and eliminate any antimicrobial 
properties by dilution, setralisation or filtration.  Either phosphate buffer ph 7.0 or fluid 
medium, used to suspend or or dilute the test specimen.  Test procedure for the 
Enterobacteriaceae and certain other Gram-negative bacteria. 
Detection of bacteria 
Homogenise the pre-treated material appropriately and incubate at 30 - 37°c for a 
length of time sufficient for multiplication of the organisms.  Shake the container, transfer 
aliquots equivalent to I gm or ml of the homogenised material to 100ml of enterobacterise 
enrichment boorth Mossel and incubate at 35 – 37°c for 18 – 48 hours.  Prepare a 
subculture on a plate with culer red bile agar with glucose and lactose.  Incubate at 35 - 
37°c for 18-48 hours.  The material process the test if no growth of colonies of Gram-
negative bacteria is detected on the plate. 
Test Procedure: 
Plate Count: 
For bacteria use peteri dishes 9-10 cm in diameter.  To one dish add a misture of 
1ml of the pre-treated herbal material and about 15ml of liquefied cascin-soyabean digest 
agar at a temperature not exceeding 45°c.  Alternatively, spread the material on the 
surface of the sobdified medium in a peteri dish.  If necessary, dilute the material to 
obtain an expected colony count of not more then 300.  Prepare two dishes using the same 
dilution, invert them and incubate them at 30-35°c for 48-72 hours, unless a reliable count 
is obtained in a short period of time.  Count the number of colonies formed and calculates 
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the result using the plate with the largest number of colonies, up to a maximum of 300.  
For fungi use peteri dishes 9-10cm in diameter.  To one dish add a mixture of 1ml of pro-
treated material and about 15ml of liquefied saborated ghucose agar with antibiotics at a 
temperature not exceeding 45°c alternatively, spread the pre-treated material as described 
above to obtain are expected coony count of not more than 100.  Prepare at least two 
distinguishing the same dilution and incubate them upright at 20-25°c for  5 days, unless a 
more reliable count in obtained in a shorter period of time.  Count the number of colonies 
formed and calculates the results using the dish with not more than 100 colonics. 
Escherichis coli: 
Transfer a quantity of the homogenised material in lactose both, prepared and 
incubated to described above, containing 1g or 1ml of the material being examined to 
100ml of MaeConkey agar and incubate at 43-45°c for 18-24 hours.  Prepare a 
subculature on plate with MacConkey agar and incubate at 43-45°c for 18-24 hours.  
Growth of red, generally non-mucoid colonies of Gram-negative tods, sometimes 
surrounded by a reddish zone of precipisation, indicates the possible of E.Coli.  This may 
be confirmed by the formation of indole at 43.5-44.5°c or by other biochemical reactions.  
The material passes the test if no such colonies are detected or if the confirmatory 
biochemical reactions are negative. 
Salmonella: 
Incubaste the solution, suspension or emulsion of the pre-treated material,l 
prepared an described above at 35-37°c for 5-24 hours, as appropriate for enrichment.  
Primary test 
Transfer 10 ml of the enrichment culture to 100 ml of tetrachionats bide brilliant 
broth and incubate at 42-43° for 18 – 24 hours.  Prepare subcultures on at least two of 
the following three agar media citrate agar, sylose, lysine deoxycholate agar, and birllen 
agar.  Incultrate at 35 – 37° c for 24 – 48 hours. 
Secondary test 
Prepare a subculture of any colonies showing the characteristics on the surface of 
triple sugar iron agar using the deep moculation technique.  This is done by first 
inoculating the needle and then, incubating at 35 – 37 c for 18 – 24 hours.  The test is 
positive for the presence of salmonella spp.  If a change of color from red to yellow is 
64 
 
observed in the deep culture (but not in the surface culture), usually with the formation of 
gas with or without productions of bydrogen sulphide in the agar.  Confirmation is 
obtained by appropriate biochemical and scrological tests.  The material being examined 
passes the test if culture of the type described does not appear in the primary test, or if the 
confirmatory biochemical and serological tests are negative. 
Staphylococcus aureus: 
Prepare an enrichment culture as described for Pseudomonas acurginos.  Prepare a 
subculture on a suitable medium such as Baird – parker agar.  Incubate at 35 - 37° c for 
24-48 hours.  The material passes the test if no growth of microrrganisms is detected.  
Black colonies of Gram positive cocci often surrounded by clear zones may indicate the 
presence Staphylococcus aureus.  For catalase-positive cocci, confirmation may be 
obtained, for exam by coagulase and deoxyribonuclese tests. 
9. TEST FOR AFLATOXIN 
The procedures recommended for the detection of Aflatoxin as per WHO (2007).   
Instrument Details:  
Name of the Instrument 
CAMAG (CAMAG - Automatic TLC sampler, 
Scanner and Visualiser) 
Spray Gas N2 
Lamp used Deuterium and Tungsten Lamp 
 
The samples were processed as per procedures recommended in WHO 2007 and 
applied for the Thin Layer Chromatography and High Performance Thin Layer 
Chromatography study with suitable solvent systems. After development the plate was 
allowed to dry in air and examined under UV – 254nm, 366nm and visible light after 
derivatised using vanillin – sulphuric acid.   
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1.Physico chemical analysis: 
Table no 1: Result of Physico-chemical analysis of Manosilai before and after 
purification with goat’s urine and Black gram water. 
 
S.No PHYSICO-
CHEMICAL 
PARAMEER 
BEFORE 
PURIFICATION % in 
w/w (mg/g) 
AFTER 
PURIFICATION 
% in w/w (mg/g) 
1 Appearance 
Dark orange colour fine 
powder 
Light orange colour fine  
powder 
2. 
pH at 25º C 
(1% w/w solution) 7.54 7.79 
3. 
Loss on Drying at 
105ºC 0.4481 %w/w 0.2953 %w/w 
4. Total Ash 4.088 %w/w 3.892 %w/w 
5. Acid Insoluble Ash 0.0809%w/w Nil 
6. 
Water Soluble 
Extractive 1.028 %w/w 0.9300 %w/w 
7. 
Alcohol Soluble 
Extractive 0.2795 %w/w 0.5559 %w/w 
8. Colour 
Dark orange colour fine 
powder 
Light orange colour fine  
powder 
 
 
 
 
 
 
. 
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2.BIOCHEMICAL ANALYSIS 
Table no.2: Result of chemical analysis of Manosilai before and after purification 
 
 
 
Experiment Sample 1 Sample 2 
1 Solubility -- + 
2 Action  Of  Heat                + + 
3 Flame Test + + 
4 Ash Test _ _ 
 
Test for acid radicals 
 
1 Test For Sulphate _ _ 
2 Test for chloride - - 
3 Test for phosphate               - - 
4 Test for carbonate + + 
5 Test for nitrate _ _ 
6 Test For Sulphide + + 
7 Test for fluoride & oxalate - - 
8    Test for nitrite _ _ 
9 Test for borate _ _ 
 
Test for basic radicals 
 
1 Test for lead _ _ 
2 Test for copper 
 
+ 
+ 
3 Test for aluminium _ _ 
4 Test for iron _ _ 
5 Test for zinc _ _ 
6 Test for calcium + + 
7 Test for magnesium - - 
8 Test for ammonium _ _ 
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9 Test for potassium + + 
10 Test for sodium _ _ 
11 Test for mercury + + 
12 Test for arsenic + + 
 
 
Miscellaneous 
 
1 Test for starch _ _ 
2 Test for reducing sugar + + 
3 Test for the alkaloids + + 
4 Test for tannic acid - - 
5 Test for unsaturated compound _ _ 
6 Test for amino acid _ _ 
7 Test for type of compound _ _ 
 
 
3. ICP-OES: 
For before and after purification of Manosilai with goats urine and boiled Black gram 
water. 
Weight of Unpurified Manosilai : 0.30315 g 
Weight of Purified Manosilai : 0.25310 g 
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Table no:3 Result of Quantitative analysis by ICP-OES for both unpurified and 
purified raw drug Manosilai with Goat’s urine and Ulundhu water. 
 
S.No ELEMENTS WAVE 
LENGTH in 
nm 
BEFORE 
    PURIFICATION  
In mg\L(PPM)    
AFTER    
      
PURIFICATION 
  In mg\L(PPM) 
1. Arsenic As 188.979 9207 7279 
2. Calcium Ca 315.807 188.7 157.5 
2. Calcium Ca 315.807 188.7 157.5 
3. Cadmium Cd 228.802 122.8 100.8 
4. Copper Cu 327.393 0.9610 0.9430 
5. Mercury Hg 253.652 4.708 2.7404 
6. Magnesium Mg 285.213 3.208 2.862 
7. Sodium Na 589.592 4.762 3.172 
8. Nickel Ni 231.604 0.014 0.002 
9. Lead Pb 220.353 0.614 0.763 
10. Phosphorus P 213.617 0.276 0.314 
11. Sulphur S 180.731 264.8 182.8 
12. Potassium K 766.490 2.200 0.48 
13 Cobalt C0228.616 0.042 O.014 
14 Iron Fe 238.204 13.62 11.87 
15 Selenium Sc 196.026 0.622 7.699 
16 Chromium Cr 267.716 0.005 0.016 
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SR No 17-03-X-2536A-160317.pk
SR No 17-03-X-2536A-160317.005  3601  4000.00  400.00  44.65  59.95  4.00  %T  16  0.30
REF 4000 55.46 2000 46.49 600
3431.75  45.58  1628.31  44.65  1424.19  44.83  1127.75  46.54  876.29   49.23  
4000.0 3000 2000 1500 1000 400.0
40.0
42
44
46
48
50
52
54
56
58
60.0
cm-1
%T 
3431.75
1628.31 1424.19
1127.75
876.29
4. FTIR 
GRAPH: 1( A) 
  Characteristic IR absorption frequencies of Organic Functional Groups for 
unpurified raw drug MANOSILAI. 
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 Result Analysis Interpretation  
 
¾ IR absorption peak at 1127.75cm-1 may be due to the presence of =S  
¾ Wide predominant peak at 3431.75cm-1 due to free O-H vibration  
¾ Medium intensity peak at 1424.19 cm-1 and 876.29 due to presence of S=O 
functional group stretching  
¾ IR absorption peak at 1628.31 cm-1 due to NH2 scissoring  
¾ Absorption peak at 1127cm-1 due to presence of C-O stretching  
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SR No 17-03-X-2536B-160317.pk
SR No 17-03-X-2536B-160317.003  3601  4000.00  400.00  42.74  60.20  4.00  %T  16  0.30
REF 4000 55.25 2000 44.10 600
3409.68  45.70  2923.80  45.89  2851.15  45.92  1629.61  42.74  1420.18  42.97  
4000.0 3000 2000 1500 1000 400.0
40.0
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
60.8
cm-1
%T 
3409.68 2923.80
2851.15
1629.61
1420.18
 
FTIR 
GRAPH:  1(B) 
 
      Characteristic IR absorption frequencies of Organic Functional Groups for purified 
raw drug MANOSILAI. 
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RESULTS 
¾ IR absorption peak at 1420.18 cm-1 due to presence of S=O functional group 
stretching  
¾ Vibrational peak at 3409.68 cm-1 maybe due to the presence of primary amine  
¾ Sharp absorption peak at 2851 cm-1 due to presence of CH stretching  
¾ Wide intense peak at 1629.61 cm-1 may be due to NH2 scissoring  
¾ IR absorbance peak at 2923.80 cm-1 due to O-H overlapping  
¾ Note the Di-sulfide bond has to be appears in the range of 500-540 but there is no 
evidence of disulfide bond  
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 Figure  1(A) 
 
 Diffractogram showing peaks of crystalline phase of unpurified raw drug 
MANOSLAI.I 
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 Figure 1( B)  
 
Diffractogram showing peaks of crystalline phase of purified raw drug MANOSLAI. 
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XRD Pattern of Reference Material  
 
 
Result Analysis of XRD pattern of Sample As2S3 Before 
• The X-ray diffraction pattern of the of the prepared formulation AsS (Before) 
reveals the presence of  major peak with 2- Theta value of 28.12 which exactly 
matches to the ICDD (International Centre for Diffraction Data) 71- 2434. ICDD 
71- 2434 corresponds to the crystalline pattern of Arsenic Sulfide (AsS) 
• Hence the reference matching material was conformed as Arsenic Sulfide (AsS) 
• Major peaks observed in Test sample AsS (Before) with 2-theta values of 28.12 
and their corresponding intensities were 1370.The major peak observed in the 
reference matching material was 28.10 with the intensity value of 415. 
• The XRD pattern of the test sample AsS (Before) exactly matches with the 
reference material AsS, which justifies the presence of stable and purified AsS in 
the formulation. 
• From the result of the present XRD analysis it was concluded that the elemental 
composition of sample AsS (Before) confirms the presence of AsS at its stable 
state. Further Mercury being the major component of the sample AsS (Before). 
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XRD Pattern of Test Sample As2S3 After 
FIGURE :2(a) 
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XRD Pattern of Reference Material 
• AsS(After) reveals the presence of  major peak with 2- Theta value of 28.12 
which exactly matches to the ICDD (International Centre for Diffraction Data) 71- 
2434. ICDD 71- 2434 corresponds to the crystalline pattern of Arsenic Sulfide 
(AsS) 
• Hence the reference matching material was conformed as Arsenic Sulfide (AsS) 
Major peaks observed in Test sample AsS (After) with 2-theta values of 28.12 and their 
corresponding intensities were 1316.The major peak observed in the reference matching  
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Result Analysis of XRD pattern of Sample As2S3 (After) 
• The X-ray diffraction pattern of the of the prepared formulation material was 
28.10 with the intensity value of 415. 
• The XRD pattern of the test sample AsS (After) exactly matches with the 
reference material AsS, which justifies the presence of stable and purified AsS in 
the formulation. 
• From the result of the present XRD analysis it was concluded that the elemental 
composition of sample AsS (After)confirms the presence of AsS at its stable state. 
Further Mercury being the major component of the sample AsS (After) 
 
6. SEM 
Figure 2(a)  
SEM image of Arsenic Disulphide (Before) – Cluster View 
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 SEM image of Arsenic Disulphide (Before) – Categorised View 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Particle Size ranges from 13.33 to 36.42 μm Average Particle size 
Shape  : Irregular 
Surface : Smooth 
Distribution : Evently Distributed   
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Figure: 2(b)  
SEM image of Arsenic Disulphide (After) – Cluster View 
 
 
 
 
 
 
 
 
 
 
 
M image of Arsenic Disulphide (After) – Categorised View 
 
 
 
  
 
 
 
 
 
 
 
 
 
Particle Size ranges from 8.4 to 21.33 μm  
Shape  : Irregular 
Surface : Smooth 
Distribution : Evently Distributed   
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 7.DETERMINATION OF MICROBIAL LOAD 
      TABLE:4 
Result of microbial load of raw drug Manosilai before and after purification with 
goat’s urine and boiled Black gram water. 
S. 
No. 
Parameters 
Reference 
Limits as per 
WHO (2007) 
Results 
Sample -2 
(Unpurified)
Sample -1 
(Purified) 
Remarks 
1 Total Bacterial Count 
(TBC) 
105CFU/gm Absent 
 
 
 
 
 
 
 
 
Absent 
 
 
 
 
Within 
permissible 
limits 
2 Total Fungal Count 
(TFC) 
103CFU/gm Absent 
 
Absent 
 
3 Enterobacteriaceae 103 Absent Absent 
4 Escherichia coli 10 Absent Absent 
5 Salmonella Spp  None Absent Absent 
6 Staphylococcus aureus None Absent Absent 
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8.ESTIMATION OF PESTICIDE RESIDUE 
TABLE :5 
      Result of  pesticide residue of raw drug Manosilai before and after purification 
with goat’s urine and boiled Black gram water given in table:5 
 
S.No Parameter Test Before 
Purification 
of Manosilai 
After 
Purification 
of Manosilai 
Organochlorine Pesticides 
1 Alpha HCH ND ND 
2 HCB ND ND 
3 Beta – HCH ND ND 
4 Gamma – HCH ND ND 
5 Delta –HCH ND ND 
6 Heptacholr ND ND 
7 Aldrin ND ND 
8 Hepachlor Epoxide 1.779 0.413 
9 Chlordane (cis & trans) ND ND 
10 Endosulfan (alpha) ND ND 
11 Endosulfan sulphate ND ND 
12 O,p’ & p,p’-DD ND ND 
13 Dieldrin ND ND 
14 O,p’ & DDD ND ND 
15 Endrin ND ND 
16 Endosulfan – Beta ND ND 
17 O,p’ & p,p’ DDT ND ND 
18 Mehoxychlor ND ND 
Organophosphorous Compounds 
19 Phorate ND ND 
20 Methyl parathion ND ND 
21 Malathion ND ND 
22 Chlorphyrifos ND ND 
23 Ethion ND ND 
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9. TEST FOR AFLATOXINS  
Result of Aflatoxin analysis of raw drug Manosilai before and after 
purification with goat’s urine and boiled Black gram water is given in table 5. 
 
The sample A(Processed 8 µl) ; Sample B( Unprocessed 10µl) and Standard  Std - 
G2,G1, B2 and B1(20 µl) were applied on TLC aluminium sheet silica gel 60 F 254 
(E.MERCK) and plate was developed using the solvent system Chloroform : acetone: 
water (14 : 2 : 0.2). After development the plate was allowed to dry in air and examined 
under UV – 254 nm, 366 nm and Visible light (Vanillin –Sulphuric acid). 
 
  
 
UV-366nm 
 
Standard – G2, G1, B2 & B1  
The test sample (A & B) does not show the evidence for the presence of any of 
the aflatoxins.   
    
Aflatoxin level in sample 1 and sample 2 was measured by AOAC 2008.02, and this 
result indicated 
 
  
Std
Densitometric chromatogram at UV-366nm 
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TABLE :6 
Result of Aflatoxin analysis of raw drug Manosilai before and after 
purification with goat’s urine and boiled Black gram water is given in table 6. 
 
PARAMETER RESULT 
                                                      Aflatoxin 
           Aflatoxin B1                        ND                       
           Aflatoxin B2                       ND 
           Aflatoxin G1                       ND 
           Aflatoxin G2                       ND 
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DISCUSSION 
The drug Manosilai of mineral origin was selected for Standardization of 
purification. The method of purification with goat’s urine and boiled black gram water 
was selected from the Siddha literature “Agathiyar vaithiya kaviyam 1500”. 
Metals and minerals are held in hand to hand in Siddha Pharmaceuticals with 
suitable as well as various process of purification.  Manosilai contain a large number of 
essential minerals in it. Therefore it has to be purified before using in the medicine 
preparation.  
Manosilai is also included in the following preparations like Sivanar amirtham, 
Kasthuri karuppu, Vishnu chakkaram, Bramananda bairavam, Gandaga sudar thailam. 
Arsenic disulphide has a therapeutic potency in the treatment of  Sarma kuttam ( skin 
leprosy) , Nalir suram( fever with  chill), Iraippu( asthma), Kannoigal(eye disease), 
Moothira kiricharam(urinary tract infection), kapha diseases. . It also has many 
indications as an external application in the form of ointment for various types of wounds. 
Purification of Manosilai is recommended before its application in the pharmaceutical 
preparation as mentioned in the Siddha literature. 
Mineral arsenicals have long been used in traditional medicines for various 
diseases yet arsenic can be highly toxic and carcinogenic. Orpiment are less soluble and 
poorly absorbed from gastrointestinal tract while the bioavailability of arsenic trioxide is 
similar to in organic arsenic salts like sodium arsenate. 
Arsenic preparations were used by many physicians in the treatment of malignant 
diseases such as leukemia, Hodgkin disease and pernicious anemia, as well as non 
malignant diseases such as psoriasis, eczema and asthma for centuries 41  
In Siddha literature, purification will be done before medicine preparation from 
Manosilai. In this study, the method of purification of Manosilai was taken from the text, 
“Aagathiyar vaithiya kaaviyam 1500 For the purpose of Standardization, the powdered 
samples of both unpurified and purified were taken and labeled as such and the following 
analysis were chosen. 
Physico-chemical analysis 
Chemical analysis 
Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) 
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Fourier Transform Infra Red Spectroscopy (FTIR) 
X-Ray Diffraction (XRD) and 
High Resonance Scanning Electron Microscopy(HR-SEM). 
Microbial Load 
Pesticides 
Aflotoxin 
The Physico-chemical analysis of drug Manosilai before and after purification 
reveals the following results. 
The pH of the drug Manosilai before purification was 7.64, which is slightly 
alkaline43 .The pH of the raw drug Manosilai after purification was changed to 7.79, 
which is alkaline 
The loss on drying test is to determine to measure the amount of water and 
volatile matter in a sample when the sample is dried under the specified conditions. 
Moisture is one of the major factors responsible for the detoriation of the drugs and 
formulations. Low moisture content is always desirable for higher stability of the drugs 43. 
The percentage of loss on drying of raw drug Manosilai before and after purification was 
changed from 0.4481 % w/w to 0.2953%w/w. The drastic change in loss on drying from 
before to after purification process depicts the extensive shelf life of the drug44 
The Ash limit tests are to determine the measure the amount of the residual. A 
high ash value is an indication of contamination, substitution, adulteration or carelessness 
in preparing the drug and the less Total ash value indicates the purity of the drug. 
The Total ash values of Manosilai for before and after purification process was 
0.4481%w/w and 0.2953%w/w respectively. As the Total ash value is much reduced in 
after purification, it implies that the inorganic constituents are much reduced after 
purification. 
The acid - insoluble ash limit test is to measure the amount of ash insoluble to 
diluted hydrochloric acid43. Acid-insoluble ash value of Manosilai before and after 
purification was 0.0809 %w/w and nil  respectively. This indicates the greater physiologic 
availability of the drug46 and also indicates the purity of the drug after purification. 
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Extraction value determines the amount of active constituents in a given amount 
of the formulation when extracted with a solvent media such as water and alcohol. The 
water soluble and alcohol soluble extract values provides indication of the extent of polar 
and non-polar compounds respectively43.The extract value of water is changed from 
1.028%w/w to 0.9300 %w/w during purification. It indicates that water solubility is 
slightly   decreased after purification. The extract value of Alcohol is changed from 
0.2795 %w/w to 0.5559 %w/w. There is a reducing Alcohol extract value in after 
purification, which indicates that the alcohol solubility is increased. Hence it is concluded 
that alcohol not is better solvent of extraction than water.,44. 
The Chemical analysis of the drug before and after purification shows the 
presence of arsenic, copper, calcium, magnesium, and carbonate 
The presence of arsenic which is required for syphilis, psoriasis, un common 
blood cancer like acute promyelocytic leukemia property found in manosilai. 
Copper is chief function is hemopoiesis,helps in synthesis of haemoglobin and 
maturation of red blood cells  ,property found in drug manosilai  
The presence of Calcium required for development of bones and teeth, muscle 
contractions, also regarded as the second messenger which facilitates the release of 
hormones from endocrine glands45 found in the drug Manosilai may be attributed to the 
rejuvenating property of the medicine prepared Manosilai. 
The presence of Carbonate and Magnesium are essential for maintenance of acid-
base balance46. 
The Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) 
analysis of raw drug Manosilai before and after purification showed that the presence of 
physiologically important minerals like Calcium, Magnesium, Sodium and Phosphorus. 
Heavy metals such as Mercury, Lead, Arsenic and Cadmium were slightly reduced than 
unpurified Manosilai. 
The Fourier Transform Infra Red Spectroscopy (FTIR) analysis of Manosilai 
purified with goat’s urine and boiled Black gram water shows the presence of vibrational 
band observation around ~ 1420 to 1629 cm-1 and confirms is attributed to the presence of 
Sulphide 47. Also shows the presence of functional groups such as Alcohol, Amine, CH, 
and NH2.48 
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The X-Ray Diffraction (XRD) analysis of the drug samples shows intensity 
peaks of various places. The peaks were identified as crystalline peaks 
The High resonance scanning Electron microscopy (HR-SEM) analyses of raw 
drug Manosilai before and after purification were done. The micrograph shows the shapes 
of the Manosilai powder were of evently distributed, irregular shapes and size ranges 
from 13.33to 36.42 Reduced to 8.4 to 21.33 the micrograph reveals the information on 
external morphology, texture and orientation of materials making up the sample50. 
Pesticide residue "Any substance or mixture of substances in food for man  and 
animals resulting from the use of a pesticide and includes any specified derivatives, such 
as degradation and conversion products, metabolites, reaction products, and impurities 
that are considered to be of toxicological significance." level were quantitatively 
measured in the raw Manosilai, the result indicated the absence of  pesticides .51 
Aflotoxin is related to mycotoxins produced by a species of Aspergillus, 
commonly A. flavus, found as a contaminant in moldy grains and meals, as in rice and 
peanut meal, and suspected of causing liver cancer in humans and other animals. Level 
were quantitatively measured in the raw manosilai, the result indicated the absence of 
Aflotoxin.52 
The microbial load was detected in both samples to ensure safety and efficacy of 
drug during ingestion .It was noted that microbial count found to absent in both samples.53 
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SUMMARY 
 Siddha system of medicine emphasis, before going to medicine preparation every 
raw drug must be purified. The concept of   Shuddhi (purification) in Siddha is not only a 
process of purification / detoxification, but also a process to enhance the potency and 
efficacy of the drug. There is no scientific evidence what all the changes occur during the 
purification process are.  
The Purification method of the chosen drug had been selected from the Siddha 
literature “Aagathiyar vaithiya kaaviyam 1500”.  The classic method of purification was 
said by the famous Siddhar Aagathiyar who is known for his excellence in various realm 
of Siddha medicine. 
For the purpose of study, 500gm of raw drug Manosilai was procured from 
renowned country drug shop in Chennai. The authentication for raw drug was obtained 
from siddha central research institute, Chennai- 06. Ulunthu was procured from Market 
and authenticated by, Botanist, Plant Anatomy Research centre, Chennai-5 
Then the raw drug was divided into two equal quantities of 250gm. One of the 
part of the raw drug was taken and powdered well and kept as such labelled as un purified 
raw drug Manosilai. The other part of the raw drug Manosilai was subjected to 
purification procedure Manosilai is made into small pieces and make in to a bundle, The 
above bundle is boiled with goat’s urine by using thula appliances and then the bundle is 
take out and kept in black gram boiled water after that the bundle is opened and dried it. 
Then it was powdered and labelled as purified drug Manosilai the qualitative and 
quantitative analyses were done for both the samples of unpurified and purified raw drug 
Manosilai. 
The physico-chemical analysis of the purified Manosilai reveals state of better 
absorption in the intestine, higher stability, purity, and Water solubility. 
The chemical analysis shows the presence of physiologically important metals and 
minerals such as arsenic, copper, Calcium, Magnesium,, Carbonate and mercury 
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The results of ICPOES analysis indicates the presence of increased concentration 
of physiologically important minerals in purified Manosilai and also slightly lower limits 
of heavy metals such as Mercury, Lead, Arsenic and Cadmium After purification. 
The results of FTIR analysis show the presence of Sulfide, Alcohol, Amine, CH, 
and NH2 48 functional groups. 
The HR-SEM analysis consists of agglomerates of various shapes and sizes in 
reduction with increase in magnification from before to after purification. The 
agglomerates were found leaving pores in between which would permit the circulation of 
body fluid throughout the coating, when it is used as a medicine. 
The XRD analysis results depicts clearly that the crystalline phase is increased 
with increase in intensity, which indicates that purified Manosilai is attributed for better 
bioavailability and dissolution rate. 
          Pesticide residue, Microbial load& aflatoxin level were quantitatively measured in 
the raw Manosilai the result indicated the absence of them.  
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CONCLUSION 
The following inferences are drawn based on qualitative and quantitative analysis 
of before and after purification of Manosilai with goat’s urine and .boiled black gram 
water. 
a. Before purification the total ash value is 4.088% w/w w After purification 
the total ash value reduced to 3.319 % w/w. It denotes the impurities are 
removed. 
b. Before purification the moisture content is 0.4481 % w/w. After 
purification the moisture content reduced to 0.2953 % w/w. It denotes that 
the shelf life is increased after purification. 
c. ICP-0ES results suggest Mercury, Arsenic and Cadmium level 
reduced after purification. 
d. Crystalline is increased which enriches better bioavailability and 
dissolution of the drug. 
Siddha system insists on Purification before using them in the pharmaceutical 
preparations. The present study of purification process of Manosilai the impurities is 
removed and the quality of the drug is improved. Therefore the purified drug when used 
in medicine preparation may increase the efficacy and potency of the medicine. The 
changes found in after purification of Manosilai indicates the necessity of purification. 
This purification process of Manosilai with Goat’s urine and Boiled Black Gram water 
can be set as one of the standard purification process of Manosilai. 
Therefore it can be concluded that after the purification of Manosilai, through the 
above purification Method, has more efficacy and safety. 
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